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ABSTRACT 
The prevalence of neonatal pneumonia exemplifies an age-related immune 
susceptibility among several mammalian species.  The cause of this age-related 
susceptibility is primarily due to different mechanisms of immune defense within the 
neonate as compared to the adult.  In horses, neonatal foals less than six months of age 
succumb to pneumonia caused by the intracellular, macrophage-tropic organism, 
Rhodococcus equi.  Fulminant pneumonia in foals caused by R. equi develops as a slow 
progression of pyogranulomatous pneumonia and causes significant morbidity and 
mortality on equine breeding farms in horses aged two to six months.   
Several studies within the literature provide explanations for this age related-
susceptibility including a delayed production of a comprehensive array of endogenous 
antibody, altered cell-mediated immune responses, and diminished cytokine production 
by T cells; however, several gaps remain with respect to pulmonary specific immune 
changes within the ageing foal.  The research reviewed in this dissertation focuses on the 
innate pulmonary cytokine milieu as well as the pulmonary alveolar macrophage (PAM) 
phenotype and function and how these immune environments and macrophage functions 
changed during the first year of life in a foal.   
Bronchoalveolar lavage fluid (BALF) was collected from a cohort of foals during 
the first year of life and analyzed during a longitudinal study investigating the pulmonary 
cytokine milieu and the PAM phenotype and function.  Increased concentrations of 
interleukin-4 (IL-4) within the BALF of neonatal foals early in life and consistent 
concentrations of tumor necrosis factor-alpha (TNF-α) within the first year of life were 
discovered.  Interestingly, IL-4 concentrations increased within the first two months of 
ix 
life and were virtually undetectable by six months of age.  Furthermore, ex vivo PAM 
were discovered to demonstrate an increased susceptibility to in vitro intracellular 
infection with R. equi despite applied stimulus.   
The final concept investigated, regarding the age-related susceptibility to 
pneumonia within neonatal horses, included measurement of naturally occurring 
circulating antigen-antibody complex concentrations.  These immune complexes were 
studied as an alternative mechanism for macrophage activation ultimately resulting in 
enhanced intracellular microbicidal killing.  Importantly, neonatal foals exhibited 
significantly lower concentrations of circulating immune complexes than adults 
providing additional evidence to support the notion that macrophages from foals are less 
capable of adopting a microbicidal phenotype.  
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CHAPTER 1.    GENERAL INTRODUCTION  
Statement of the Problem 
Pneumonia is the single largest cause of death from infectious agents in children 
worldwide and accounts for 16% of all deaths of children under five years of age [1].  
Despite the prevalence of pneumonia in children, adults suffer much less commonly from 
pneumonia.  Even so, if adults develop pneumonia, the inciting factor is often related to 
concurrent sickness and hospitalization resulting in a community acquired pneumonia 
[2].  Still, less than 1% of adults under the age of 65 years develop community acquired 
pneumonia [2].  This well recognized age-related disparity of susceptibility to pneumonia 
is prevalent across all species.  Rhodococcus equi is an important cause of foal 
pneumonia and is the leading cause of morbidity and mortality among foals aged one to 
six months [3].  While prevalent in foals aged less than 6 months, the disease is rare in 
adult horses, suggesting a difference in functional immunity [or a susceptibility].  The 
underlying causes for enhanced susceptibility in neonates and children are incompletely 
understood; however, it is known that their innate and adaptive immune responses are 
plastic and appear dependent on conditions of antigen and immunogen exposure.   
Furthermore, the pulmonary immune response to antigen and immunogen is a 
complex interplay of events, and factors such as cytokines are well known for influencing 
macrophage phenotypes [4, 5].  Macrophage phenotype determines the extent of reactive 
oxygen species production [5].  Lack of production of reactive oxygen species (ROS) and 
nitrogen species (RONS) by alveolar macrophages has been documented in fulminant 
early-onset neonatal pneumonia [6], indicating a dampened response in fundamental lung 
defense mechanisms during this developmental period.  
2 
 
The macrophage phenotype and regulation of RONS are influenced by cytokines 
and chemokines indicating that the cytokine milieu of the phagocyte upon exposure to an 
antigen or immunogen is formative to the phagocyte’s response.  However, how the 
cytokine milieu of the neonatal vs. adult lungs contributes to production of RONS by 
tissue macrophages and pulmonary alveolar macrophages is not fully understood.  
Nonetheless, appreciation of the importance of innate macrophage responses to infection 
is garnering increased attention in the field of immunology; indeed, novel macrophage 
activation mechanisms that increase RONS production resulting in a consequential 
microbicidal effect are being explored and may hold promise for alternative antimicrobial 
strategies.  
Interestingly, controversy exists as to whether foals have a bias for an anti-
inflammatory or a pro-inflammatory immune response.  For example, Wagner et al. 
investigated PBMC from neonates and found that they were unable to produce IL-4 
following in vitro stimulation [7].  A conclusion was made that foal peripheral blood 
mononuclear cells (PBMC) were virtually incapable of producing IL-4, and foals 
demonstrated Th1- or pro-inflammatory- bias.  Contrastingly, Breathnach et al. 
determined that foals were interferon-gamma deficient following collection and in vitro 
stimulation of peripheral blood mononuclear cells (PBMC) and bronchoalveolar cells 
from 1, 3, and 6-month-old foals [8].  Breathnach et al. supported the notion that foals 
were generally Th2 biased while Wagner et al. concluded foals were not capable of Th2 
responses [7, 8].  Thus, despite different context dependent studies that reached 
conflicting conclusions, these previous in vitro studies also represent experiments 
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whereby the methods effectively removed these cells from their local immune 
environment without first determining the cytokine exposure of those immune cells.   
Thus, in addition to controversy regarding Th bias, or anti- vs. pro-inflammatory 
immune responses within foals, another major problem is the lack of site-specific 
immunomaturation information evaluating the local immune environment.  To our 
knowledge, no cohort-based longitudinal studies have been performed that characterize 
pulmonary cytokine milieu changes from neonate to adult either within the equine or 
human pulmonary system.  Furthermore, it therefore remains unclear how the cytokine 
milieu impacts the macrophage phenotype and resulting function.  A better understanding 
of this process could enhance the knowledge regarding not only the predisposition of the 
young, but, also, how the immune system of the young vs. mature spatially and 
temporally differs from adults.  This knowledge is expected to ultimately increase the 
future development of novel treatments for pneumonia in neonatal foals and, potentially, 
children.  
 
Specific Aims 
The overall goal of the studies performed in this dissertation is to better 
characterize the pulmonary immune environment and reveal qualitative and quantitative 
site-specific differences that may account for why the foal is more susceptible to 
developing pneumonia caused by Rhodococcus equi compared to the adult horse.  The 
first specific aim is to determine the extent to which circulating and alveolar 
macrophages from neonatal foals and adult horses produce ROS and RONS.  The 
working hypothesis for this aim is that macrophages from foals do not produce reactive 
oxygen and nitrogen intermediates (such as superoxide and peroxynitrite, respectively) at 
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levels similar to adult horses, which, in part, may account for their susceptibility to 
disease.  The second specific aim is to determine the extent to which the cytokine milieu 
surrounding the macrophage affects macrophage phenotype and production of reactive 
oxygen and nitrogen intermediates.  The working hypothesis for this aim is that 
macrophages from neonatal foals are exposed to a Type 2 cytokine milieu, namely IL-4, 
IL-13, IL-5, and IL-10, and consequently do not produce reactive oxygen and nitrogen 
intermediates at levels similar to adult horses.  The third specific aim is to determine the 
extent to which circulating antigen-antibody complex concentrations differ in the foal vs. 
the adult horse in order to provide additional insight regarding the potential influence of 
these circulating antigen-antibody complexes on macrophage phenotype and function 
within the neonatal foal.  The working hypothesis for this aim is that foals have lower 
concentrations of circulating antigen-antibody complexes due to decreased antigen 
exposure as compared to the adult and are therefore less able to shift their macrophage 
phenotype from a regulatory or tissue repair macrophage to a classically activated 
macrophage.  
These hypotheses were tested by collecting peripheral blood and bronchoalveolar 
lavage fluid (BALF) from foals during the following ages of development: one week, one 
month, two months, 6 months, and 12 months of age in order to measure baseline 
cytokine concentrations as well as investigate the phenotype and function of peripheral 
and alveolar macrophages.  The BALF was analyzed via ELISA for IL-4 and TNF-α for 
the aforementioned time points in foals (Chapter 2).  Furthermore, the pulmonary 
cytokine milieu change in response to immunogen was investigated in the aging foal.  
Pulmonary alveolar macrophages (PAM) were isolated from BALF collected from 
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neonatal foals and adult horses and studied for production of ROS and RONS following 
in vitro stimulation in foals and adults (Chapter 3).  Finally, serum from neonatal foals 
and adults was analyzed for circulating, soluble, antigen-antibody complexes and the 
concentrations were compared (Chapter 4). 
 
Dissertation Organization 
This dissertation describes the changes of the pulmonary cytokine milieu within 
the aging foal, comparing IL-4 and TNF-α BALF concentrations during the first year of 
the foal’s life.  Additionally, the foal’s individual response to antigen or immunogen both 
within the in vivo pulmonary environment, and from isolated ex vivo macrophages 
stimulated in vitro was explored.  The final concept investigated includes characterization 
of concentrations of circulating antigen-antibody complexes within neonatal foals as well 
as these antigen-antibody complexes’ ability to induce production of ROS following 
macrophage stimulation.  The dissertation is composed of five chapters and an appendix 
with the first chapter as the general introduction and literature review.  Chapters 2, 3, and 
4 are composed of the three individual manuscripts being prepared for the peer review 
journal submission, with the final chapter (Chapter 5) as conclusions and future 
directions.  
The first and second papers (Chapters 2 and 3) are being submitted to the Journal 
of Veterinary Immunology.  The third paper (Chapter 4) is being submitted to the Journal 
of Equine Veterinary Education.  Finally, the appendix includes a modified version of a 
previously published journal article from the Journal of Veterinary Clinical Pathology in 
which age-related changes of the BALF cellular composition in neonatal foals and adult 
horses is characterized.  
6 
 
Literature Review 
Scope 
The scope of this literature review will focus on the developing immune system 
specifically within the foal and how increasing this knowledge can elucidate novel 
avenues for the prevention and treatment of disease, specifically pneumonia, for horses as 
well as other species, including humans.  A background will be provided covering a 
general overview of Rhodococcus equi and its pathogenesis, as well as diagnosis and 
treatment of rhodococcal pneumonia in foals.  The current knowledge regarding neonatal 
immunity will be covered with a focus on comparing the differences between the equine 
neonate and adult regarding the innate and adaptive immune responses.  Finally, an 
explanation of the value of the equine lung as a model for pulmonary immunology 
studies will be explored. 
 
Rhodococcus equi  
Rhodococcus equi (R. equi) is an aerobic gram-positive, coccobacillus, facultative 
intracellular bacteria that lives in the soil, is found within fecal material from herbivores 
world-wide, and is an important pathogen among foals, farm animals, and humans [9-12].  
Over the past three decades, R. equi has gained notoriety for infecting 
immunocompromised humans such as HIV/AIDS and transplant patients [13-16] and 
most recently for recurrent meningitis following pneumonia in a human patient [17].   
This multi-host pathogen is also known to cause diseases in a variety of other 
domestic animals.  R. equi can be isolated from 3-5% of apparently healthy pigs usually 
from their submandibular lymph nodes [18].  R. equi has also caused disease in swine 
that usually are presented with granulomatous lymphadenitis [18-21].  However, 
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experimental infection studies have failed to reproduce granulomatous lymphadenitis in 
pigs [19-22].  
An abattoir survey in Ireland between 1997-98 found 4% of tuberculosis-like 
granulomas present in the retropharyngeal, bronchial and mediastinal lymph nodes from 
cattle contained R. equi identified by culture [18, 23].  Bronchopneumonia, mastitis, 
metritis, ulcerative lymphangitis, and septic arthritis have also been diseases in cattle 
caused by R. equi [12, 18].  In smaller domestic species, such as the cat and dog, R. equi 
has been a documented cause of several diseases ranging from pneumonia, wound 
infections, subcutaneous abscesses, vaginitis, and hepatitis, to osteomyelitis, myositis, 
and joint infections [24].  
Three species adapted virulence plasmids known as VapA, VapB, and VapN are 
currently recognized for R. equi and each type can be isolated from the equine, bovine, 
and porcine species, respectively [25].  However, any of these plasmids can be isolated 
from humans infected with R. equi suggesting a potential for zoonosis [25-26].  A 
pathogenicity island is located within each of these plasmids which are acquired by 
horizontal gene transfer [25, 26].  These plasmid types differ in genetic composition; 
however, all contain a novel family of genes known as the virulence associated proteins 
or vap family [25-27]. 
Previous experimental studies have demonstrated that the major virulence 
determinant, VapA, which is encoded on the pVAPA-type plasmid, is crucial for 
bacterial replication within macrophages and acts through disrupting normal development 
of the phagosome [18, 25, 28].  Specifically, once phagocytized, VapA enables avoidance 
of intracellular killing by the host through disrupting the events proceeding the phago-
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lysosome fusion and lysosome reformation allowing replication of R. equi to cause a 
pyogranulomatous abscess [29]  
Due to its virulence mechanism, R. equi is most recognized for the cause of severe 
pyogranulomatous pneumonia in foals and poses a significant economic burden on the 
equine breeding industry [18, 30].   
 
Diagnosis and treatment of pneumonia caused by Rhodococcus equi  
Due to the slow spread of this granulomatous disease and the foal’s ability to 
compensate during the primary stages of the disease, early diagnosis of pneumonia 
caused by R. equi can be challenging.  When pulmonary disease is apparent, foals are 
presented with the following clinical signs: nasal discharge, cough, tachypnea, fever, and 
lethargy.  Foals may also be presented with other extrapulmonary disorders; however, for 
the scope of this literature review, diagnosis and treatment of pneumonia will remain the 
focus.  
In addition to pneumonia, extrapulmonary lesions caused by R. equi are also 
common.  Intestinal lesions caused by R. equi are characterized by multifocal ulcerative 
enterocolitis and typhlitis over the area of Peyer’s-patches with granulomatous or 
suppurative inflammation of the mesenteric and or colonic lymph nodes and foals 
afflicted with abdominal abscesses have a poor prognosis [18, 31].  A study reported that 
up to 50% of foals with R. equi have intestinal lesions that are found during necropsy [18, 
31, 32].   
Furthermore, bacteremic spread of the organism from the lungs or gastrointestinal 
(GI) tract can result in septic arthritis or more commonly osteomyelitis [18, 31].  
Occasionally, foals develop septic arthritis or osteomyelitis without apparent lung 
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involvement.  Another extrapulmonary disorder that occurs in foals with R. equi is 
immune mediated inflammation within the joints and is present in approximately one-
quarter to one-third of all affected foals [18, 31, 33].   
Taking all extrapulmonary disorders into consideration, a study examined 150 
foals with R. equi that were admitted to a teaching hospital [34].  At least 1 of 39 
extrapulmonary diseases was identified in 74% of cases and survival was significantly 
lower among foals with extrapulmonary disease: 43% compared to 82% in foals only 
with pneumonia [18, 34]. 
An accurate diagnosis depends on the signalment and history of the foal.  Foals 
are usually presented between 3 weeks and 5 months of age and the farm from which 
they are presented often has a history of previous cases of pneumonia caused by R. equi 
[31].  A thorough physical examination should be conducted.  Bronchovesicular sounds 
can be appreciated during lung auscultation and these are commonly referred to as 
‘rattles’.  A complete blood count should be performed and often will reveal a 
leukocytosis, neutrophilia and hyperfibrinogenemia.  Thoracic radiographs and 
ultrasound can take place to confirm the presence of granulomatous lesions within the 
pulmonary parenchyma.  A trans-tracheal wash can be executed for definitive culture of 
R. equi [18, 31]. 
Treatment of the organism includes combination antibiotic therapy including a 
macrolide and rifampin.  Clarithromycin is the preferred macrolide as it is lipophilic and 
is found to have a greater concentration within the pulmonary epithelial lining fluid and 
the alveolus [35].  Supportive care may include nasal oxygen insufflation, intravenous 
fluid therapy, hyperimmune plasma and anti-inflammatory therapy.  Depending on the 
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severity of the disease, treatment can extend from three weeks up to 12 weeks and 
beyond. 
Breeding farms with a known history of rhodococcal pneumonia have adopted 
screening methods in order to identify which subclinical foals should be treated with 
antibiotics [36].  Breeding farms have used ultrasound as a screening tool for subclinical 
disease cut-offs, including either a sum of all lesions or an abscess score.  In one scoring 
system, a score of 1-10 cm or less and the foal lesion scores were considered below the 
cut-off.  Thus, treatment was deemed unnecessary as these lesions were considered likely 
to resolve on their own; however, no controlled studies were performed evaluating this 
method.  Antimicrobial resistance of R. equi is of great concern and these various 
screening methods adopted across breeding farms have been implicated as a possible 
potentiating mechanism of resistance to antibiotics.  Two independent studies in 2012 
showed that 80-90% of foals with subclinical disease on endemic farms cleared the 
infection without treatment [37, 38].  However, the problem remains that there is no way 
to ascertain which foals with subclinical disease will progress and develop clinical 
disease requiring treatment.   
Reported in 2017, resistance to macrolides and rifampin in isolates of R. equi 
cultured from horses is increasing, with isolates resistant to all macrolides and rifampin 
now being cultured from up to 40% of infected foals at several farms [39].  This trend 
makes increasing knowledge, regarding the immunologic susceptibility of foals, 
paramount to uncovering potential, new avenues of alternative treatments.  
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Neonatal immunity 
While pneumonia caused by R. equi is prevalent in foals aged less than 6 months, 
the disease is exceedingly rare in adults, suggesting a deficit in functional immunity.  As 
an intracellular macrophage-tropic organism, R. equi has a pathogenesis similar to 
Mycobacterium tuberculosis and is able to evade the host’s immune system within 
neonates and immunocompromised patients [18, 29, 31, 40].  The immune response 
against intracellular macrophage-tropic organisms is a complex interplay of events 
involving both the innate and adaptive immune response working in concert to protect the 
host.  Major differences have been identified among neonates and adults. 
As the innate immune system is the first line of defense against pathogens, it also 
greatly influences the adaptive immune response.  Microbial organisms are recognized 
through a set of molecular pattern recognition receptors present on the extracellular or 
intracellular membranes of many cells.  These bacterial and viral patterns are recognized 
through a family of receptors known as the Toll-like-receptors and C-type lectins.  Once 
these receptors recognize a pattern, they signal through various downstream cellular 
mechanisms and this signaling often results in the production of cytokines and 
chemokines which influence the surrounding cellular milieu and lay the foundation for 
the subsequent immunologic events.  
 Effects of cytokines can either be from the cytokine or the degree of the 
cytokine’s receptor expression profile.  Nonetheless, if recognized, cytokines are well 
known for influencing macrophage phenotypes.  Regarding rhodococcal pneumonia, 
determining the baseline pulmonary cytokine milieu within the neonatal foal would be 
expected to reveal potential reasons why foals are susceptible to developing pneumonia 
from R. equi [4, 5, 41].  The current areas of research that need further investigation, 
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which are applicable to these studies, include age-related and site-specific information 
regarding the pulmonary cytokine milieu, and changes vis-à-vis macrophage 
immunophenotypic responses and activation.  
Macrophage activation status directly correlates with resolution of R. equi disease.  
Lack of production of nitric oxide and peroxynitrite by alveolar macrophages has been 
documented in fulminant early-onset neonatal pneumonia [6], indicating an age-related 
deficit in fundamental defense mechanisms during this developmental period.  Indeed, 
two of the most important effector systems of macrophages that are paramount to innate 
immune responses include the NADPH oxidase (also known as phox) and inducible nitric 
oxide synthase (iNOS) pathways which account for the generation of superoxide (O2– •) 
and nitric oxide (NO•) radicals, respectively.   
Together, superoxide and nitric oxide can form the highly reactive molecule, 
peroxynitrite [42, 43].  These three reactive intermediates have broad antimicrobial 
effects and their use as effector molecules is conserved across the plant and animal 
kingdoms [44-46]. 
Concerning the general categorization of macrophages and their production of 
reactive intermediates, classically activated macrophages are efficient at producing free 
radicals and thereby are effective killers of intracellular pathogens while regulatory and 
tissue repair macrophages are inefficient killers [4, 5].  In recent years, experiments 
investigating the effect of cytokine priming on macrophage function following in vitro 
infections with R. equi have been studied using adult equine macrophages.  Of note, pro-
inflammatory cytokines like tumor-necrosis factor-alpha (TNF-α) and interferon-gamma 
(IFN-γ) were found to improve intracellular killing of R. equi [47].  Additionally, 
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macrophages of different lineages and from different ages of foals were harvested and 
infected, ex vivo, with R. equi.  According to Berghaus et al., regardless of the 
macrophage lineage, foal macrophages at three months of age permitted higher 
replication of intracellular R. equi and, overall, alveolar macrophages were more 
susceptible to a higher bacterial load [48].   
Given the direct impact that cytokines have on macrophages, these professional 
phagocytes also produce cytokines in response to not only their immediate environment, 
but in response to pathogen recognition.  The cytokines that macrophages produce can be 
used to characterize their phenotype, as well.  Consistent with current data, our previous 
work indicated that stimulated monocyte-derived macrophages (MDM) from neonates 
produce more IL-10 than similarly derived macrophages from adults, suggesting a 
fundamental difference in cytokine production between neonates and adults [49].   
Antigen presenting cells, like the macrophage, represent the bridge between the 
innate and the adaptive immune system as they present processed antigen to T cells and B 
cells through their MHC receptors, which subsequently become activated, provided the 
appropriate signals are present, and orchestrate the immediate antibody and/or cell-
mediated response.   
Concerning the adaptive immune response, variations between the neonatal and 
adult immune system have been documented [50].  Importantly, Hostetter et al. 
demonstrated a significantly decreased lymphocyte population within the BALF of foals 
compared to adults [51].  The key players of the adaptive immune response are 
lymphocytes which can be divided into several categories including T-helper cells, 
cytotoxic T cells, and B cells.  Of the T cell population, CD4+ and CD8+ cells, in 
14 
 
particular, are important regarding initiation and maintenance of cell-mediated immunity, 
T cell mediated cytotoxicity, and B cell expansion, proliferation and antibody isotype 
class-switching as well as the formation of a memory response [49].  As such, 
lymphocytes have been extensively studied from aging foals [7, 8, 53-56].   
Interestingly, CD4+ and CD8+ cells occur in significantly fewer numbers in 
neonatal horses than adult horses and were found to increase linearly in foals up to 3 
months of age [54].  This delay in CD4+Th cell development poses a risk for neonatal 
horses especially concerning intracellular pathogens.   
IFN-γ is an important cytokine causing antimicrobial activity against intracellular 
pathogens, like R. equi.  IFN-γ not only activates the adaptive immune system while 
promoting the development of high-affinity antigen-specific T and B cell responses and 
immunological memory but also directly acts on neighboring endothelial and epithelial 
cells to promote an antimicrobial state [58].  Decreased IFN-γ production from Th1 cells 
and cytotoxic T cells has been observed shortly after birth and only gradually increases 
over the first year of life [8, 31, 59].  Given this ineffective IFN-γ production in foals, a 
great disadvantage prevails for successful resolution of pneumonia caused by R. equi.    
Regarding the humoral portion of the adaptive immune response, foals rely 
heavily on maternal antibody as their own humoral system begins to slowly produce 
endogenous antibody.  Maternal immunity greatly impacts the immune system of the 
developing fetus and the acquisition of passive immunity is solely influenced by the 
maternal-fetal placenta.  Equine fetal growth occurs through an epitheliochorial placental 
maternal-fetal unit which impedes the transfer of maternal antibody (mtAb).  Thus, foals 
are born with a paucity of circulating maternal antibody until they ingest colostrum from 
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the mare.  This period between birth and colostrum ingestion is critical and imposes great 
potential for the foal to develop sepsis if passive transfer of immunity is not achieved.  
Within three hours after birth, the foal should ingest colostrum in order to remain 
protected against infectious diseases [60].  The ingested mtAb protects the foal against 
several infectious diseases during the diminution of colostral antibody and the 
simultaneous increase in endogenous antibody.  Additional factors including T cells and 
cytokines are adsorbed along with mtAb and are thought to influence the foal’s immune 
system [59].  
Concerning endogenous production of the seven different immunoglobulin-g 
isotypes within the foal, a few isotypes undergo early development before birth and 
mature within the foal by 3 months of life and include IgG1, IgG3, IgG5 as well as 
immunoglobulin-A (IgA).  However, IgG4, IgG7 as well as immunoglobulin-E (IgE) 
develop at a slower rate during the first year of life [59].  Each antibody isotype varies in 
its effector function although a few have an overlapping effector function.  According to 
Lewis et al. 2008, IgG1, IgG3, IgG4, IgG5 and IgG7 have the ability, once complexed 
with antigen, to elicit a strong respiratory burst from macrophages and are presumed to 
have great affinity to Fc receptors [61].  Regarding complement activation, immune 
complexes of IgG1, IgG3, IgG4 and IgG7 all bind C1Q and activate the classical 
complement pathway [61].  IgG2 and IgG6 did not induce a respiratory burst or bind 
complement and were implied as undesirable isotypes to produce during vaccination, 
although this is context dependent and can change depending on the immune 
environment [58].  Concerning any antibody isotype, foals have been reported to have 
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attenuated responses to vaccination prior to six months of age due to interference of 
mtAb as well as inefficient Th2 responses [59, 62].   
Collectively, these studies demonstrate that foals have decreased Th1 and Th2 
responses, both pro- and anti-inflammatory immune responses, decreased numbers of 
circulating CD4+ and CD8+ T cells during the first few months of life, fewer 
lymphocytes and higher numbers of macrophages within BALF (Figure 1-1) and reduced 
responses to vaccines.  The greatest impact that manifests as a consequence of these 
aforementioned age-related immunologic differences between foals and adults is perhaps 
foal pneumonia caused by Rhodococcus equi.  Thus, experiments that increase the 
information regarding site-specific immunologic knowledge as an aid to explain the 
discrepancies documented within the literature are not only critical for the field but would 
potentially uncover treatment options for immunomodulation of foal pneumonia caused 
by the intracellular pathogen, R. equi.  
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Figure 1-1. Cell populations within bronchoalveolar lavage fluid (BALF) from 
young foals are dominant in macrophages. Bronchoalveolar lavage fluid samples from 
foals, during their first year of life, were submitted to the Clinical Pathology department 
at Iowa State University, College of Veterinary Medicine for analysis.  A cytospin was 
generated and a 300-cell count differential was performed.  Cell populations are shown as 
a percentage of total cells within the differential.  Macrophages decreased over time (p < 
0.0001) and lymphocytes increased over time (p < 0.0001).  No significant changes in 
neutrophils or any other cell type were appreciated.  By twelve months of age, foals had 
similar populations of cells compared to their adult counterparts.  
 
Equine model for pulmonary studies 
Pneumonia caused by R. equi naturally occurs only within foals and not adults, 
making the horse an ideal species to study neonatal pulmonary immunologic responses in 
order to reveal critical differences between the neonate and the adult immune system.  
Moreover, given the intraspecies parallel between susceptibility to development of 
pneumonia caused by R. equi in both foals and immunocompromised humans, the equine 
model provides many advantages when seeking to understand developing pulmonary 
immunomaturation. 
The equine neonatal model has several inherent strengths in that pulmonary 
alveolar and monocyte-derived macrophages may be repeatedly obtained with relative 
ease and in sufficient quantities to carry out immunologic studies.  The pulmonary 
anatomy of the horse is more similar to the human than the murine model for several 
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reasons.  These similarities are demonstrated both grossly as well as ultra-structurally 
[63-66].   
First, the lobular and branching pattern within the horse more closely resembles 
the human than the mouse.  Anatomical terminology may differ among various 
researchers and in order to develop consistent terminology system, Nakakuki, a 
comparative anatomist, studied various mammal lungs and developed a consistent 
terminology making comparison between mammals unified.  As such, the equine lung is 
divided into the cranial and caudal lobes via the cardiac notch on each side.  Within the 
right lung, the accessory lobe is also present. Concerning the bronchial branching 
patterns, the equine lung is divided into four bilateral sections: the cranial, middle, caudal 
and accessory lobes [63].  When examining the bilateral bronchiole organization on 
either side, the bronchioles are divided into the dorsal, lateral, ventral and medial sections 
[63].  
Furthermore, on the dorsal aspect of the lung, the first bronchiole from the dorsal 
bronchiole system forms the cranial lobe [63].  On the lateral aspect, the middle lobe is 
formed by the first bronchiole of the lateral bronchiole system.  The accessory lobe 
originates from the first bronchiole of the ventral bronchiole system.  Finally, the 
remaining bronchioles of the dorsal, lateral and ventral bronchiole systems and all 
bronchioles of the medial bronchiole system constitute the caudal lobe [63].  The equine 
branching pattern resembles the human branching pattern closely; and both are known as 
an irregular dichotomous or trichotomous bronchiole branching pattern while mice 
display a primarily monopodial branching pattern [66, 69].   
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Concerning the histopathologic features of the pulmonary associated lymphoid 
tissue, Mair et al. studied the distribution of mucosa-associated lymphoid tissue along the 
equine respiratory tract using light microscopy to evaluate histologic sections [67].  This 
study determined that extending from the nasal vestibule to bronchioles, measuring 2 - 4 
mm in diameter, intra-epithelial lymphocytes were present in the lamina propria with 
isolated lymphoid patches and occasional nodules were common in the bronchioles, 
referred to as bronchiole-associated-lymphoid-tissue (BRALT).  However, the density of 
this pattern was highly variable among the 10 horses of various breeds ranging in age 
from 2 to 12 years that were surveyed [67].  Bronchus-associated lymphoid tissue 
(BALT) was infrequently encountered while nasal-associated lymphoid tissue (NALT) 
nodules were dispersed throughout the nasal cavity, nasopharynx and adjacent to the 
auditory tube within the upper respiratory tract.  Additionally, laryngeal- and tracheal-
associated lymphoid tissue (LTALT) was also identified, but this was limited to the 
epiglottis, arytenoid and rostra1 trachea.  Within these locations, discrete lymphoid 
masses were comprised of primary or secondary nodules, a parafollicular zone and a 
dome area.  Above these discrete lymphoid masses, Nakakuki documented a lympho-
epithelium with infolding patterns that potentially functioned to enhance antigen-trapping 
[63]. 
The presence of BALT in horses and humans is also similar although there is 
much variation between individuals, and the presence of BALT in humans has been 
regarded as controversial.  However, Kawamata infers that BALT in humans is involved 
in the initiation of bronchopulmonary immune responses to inhaled antigens and 
pathogens [65].  This conclusion was also reached regarding horses in a study 
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investigating the histological features of the equine pulmonary system [67].  The equine 
pulmonary system contains a complex and dynamic local lymphoid system extending 
from the nasal cavity to the bronchioles and is most likely the result of stimulation from 
particulate matter and microbial organisms [68].  Ultimately, unlike the rodent model [66, 
69], the gross and microscopic anatomy and presumed function make the horse an ideal 
model to study respiratory disease affecting neonates and young organisms as a result of 
immunologic differences. 
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Abstract 
Many intracellular pathogens, like Rhodococcus equi , preferentially cause 
pneumonia in the young and immunocompromised across species.  Specifically, foals 
less than six months of age suffer from pneumonia caused by Rhodococcus equi  while 
adult horses do not succumb to this disease.  This naturally occurring disease model 
highlights a critical immunologic difference between neonatal and young species vs. their 
adult counterparts.  Although many advances have been made exploring the adaptive 
immune response within neonatal horses, none have investigated the innate pulmonary 
cytokine milieu and how this milieu changes as the foal ages as well as in response to 
immunogen.  Cytokines affect several cellular processes and can either up-regulate or 
down-regulate inflammation.  Related to the pulmonary immune environment, pro-
inflammatory cytokines impact macrophage activation status and can influence their 
microbicidal activity against macrophage-tropic organisms like R. equi.  Our central 
hypothesis is that the cytokine milieu within the BALF is biased toward an anti-
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inflammatory or regulatory milieu early in a foal’s life. Specifically, we hypothesized that 
foals would have increased concentrations of interleukin-4 (IL-4) and lower 
concentrations of tumor necrosis factor-alpha (TNF-α).  To test our hypotheses, BALF 
was sampled from a cohort of foals at week 1, 4, 8, 26, and 52 weeks of age and analyzed 
to determine the cytokine milieu concentration across the first year of life.  
 
Introduction 
Pneumonia remains the number one killer of young children globally and is 
responsible for an estimated mortality rate between16 and 18% of children under 5 years 
of age [1, 2].  An estimated 120 million new cases of pneumonia in children occur 
globally each year [1].  In contrast, pneumonia in adults is significantly less common [3].  
This suggests an underlying susceptibility of the immune system in neonatal and young 
mammals.  In particular, foals suffer from pneumonia caused by Rhodococcus equi  
whereas adult horses do not acquire pneumonia caused by R. equi.  The bacterial species, 
R. equi, co-evolved in concert with the equine species and its ability to cause pneumonia 
in neonatal foals highlights a unique infectious disease development process only 
observed within foals less than six months of age.  While neonates have an increased 
susceptibility to multiple pathogens, there is a dynamic immune process occurring 
between R. equi and neonatal foals resulting in pneumonia but only in the young host.  
This represents a naturally occurring disease model and provides an exceptional 
opportunity to understand intracellular pathogens in the context of a neonatal immune 
system.  
Classically activated macrophages are potent killers of intracellular 
microorganisms by their upregulation of reactive intermediates although other 
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phenotypes of macrophages, that are less able to kill intracellular organisms, exist as well 
[4].  Macrophage activation status depends on their immediate immune environment [4].  
R. equi is an intracellular macrophage-tropic organism that evades the macrophage 
phagolysosome through its virulence plasmid, VapA [5]. Given that infection with R. 
equi is acquired through inhalation and preferentially infects pulmonary alveolar 
macrophages causing pneumonia, understanding the immediate immune environment of 
the lung within the neonate is imperative in order to determine its implicit impact upon 
the macrophage.  
Previous work has been performed investigating the expression of the cytokine-
specific mRNA profile from bronchoalveolar lavage fluid (BALF) cells as well as from 
peripheral blood mononuclear cells (PBMC) from foals.  To date, there is a lack of 
information regarding a longitudinal characterization of the extracellular cytokine milieu 
in neonatal foals specifically within the lung.  The aim of this study was to characterize 
the pulmonary cytokine milieu by measuring the concentration of a pro-inflammatory 
cytokine, tumor necrosis factor-alpha (TNF-α), as well as an anti-
inflammatory/regulatory cytokine, interleukin-4 (IL-4), present in the BALF. Samples 
were acquired from a cohort of neonatal foals beginning during the first week of life and 
were collected until one year of age.   
Determining the balance of cytokines present within the pulmonary BALF from 
foals was expected to provide insight regarding the relative exposure of pulmonary 
alveolar macrophages (PAM) to either a pro-inflammatory or anti-inflammatory 
environment.  The central hypothesis of this work is that the neonatal pulmonary cytokine 
milieu is biased toward an anti-inflammatory or regulatory milieu. To test this hypothesis, 
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BALF was acquired from 12 foals at the following time points: 1 week, 4 weeks, 8 
weeks, 26 weeks, and 52 weeks of age.  At each time point, on day 0 the left lobe of the 
lung was used as the control side and BALF was collected from the left side first.  Sterile 
PBS was instilled into the left lobe.  Subsequently, a baseline BALF sample from the 
right lung was acquired from the right lobe of the lung.  Then, heat-killed R. equi was 
instilled into the right side of the lung.  From each side of the lung, BALF was then 
collected on day 1 and day 4 after heat-killed R. equi instillation in order to study the 
response to an immunogen within the neonatal lung.  Heat-killed R. equi was instilled 
into the lung to determine if the foals would exhibit a pro-inflammatory response over 
time reflecting a progressive decrease in susceptibility to pneumonia as foals age.   
 
Materials and Methods 
 
Experimental Design 
In this longitudinal study, BALF sampling started during the neonatal period of 
the foal and extended through to sexual maturity as immunocompetency of the lung was 
acquired.  The equine model affords collection of ample material from a neonate, the 
opportunity to prime a selected bronchus with an immunogen and collect bronchoalveolar 
lavage samples from the same site at repeated intervals, a contralateral bronchus for intra-
animal saline control, and a time to maturity that accommodates studies of 
immunomaturation.  Moreover, this equine model takes advantage of: (1) R. equi, a 
respiratory pathogen of horses known to infect neonates but that is effectively cleared by 
the adult, (2) our recent contribution documenting an anti-inflammatory/regulatory 
cytokine bias to equine neonatal macrophage responses [6], and (3) the pulmonary 
30 
 
anatomical and immunologic similarities between the horse and human providing a 
potential platform for translational neonatal immunologic results.   
 
Animals  
Twelve foals, of various breeds (Thoroughbreds and Quarter Horses), were used 
for this study which was approved by the Iowa State University Animal Care and Use 
Committee.  The foals were born at the Iowa State Research Barn in Ames, IA.  Within 
the first 48 hours of life, a physical exam, CBC, serum biochemistry, status of passive 
transfer of antibody and a complete history were assessed to assure healthy subjects.  
This age of foal was selected as (1) it is most likely to demonstrate functional differences 
when compared with the adult; (2) the rate of functional maturation of equine 
macrophages is unknown; and (3) infection with R. equi is posited to occur within the 
first two weeks of life [7].  Due to attrition of the subjects, an incomplete data set was 
collected and analyzed.     
Foals were housed with their respective dams in a separate facility from the rest of 
the herd.   All foals were weaned from their dam around four months of age.  All dams 
and weaned foals were kept on a dry lot and were fed a mix of alfalfa and grass hay with 
supplemental complete pelleted feed.   
 
Immunogen Preparation 
Rhodococcus equi , strain T194, was provided as a clinical isolate from a 
pneumonic foal by Dr. Ronald Griffith, Iowa State University.  A single colony was 
seeded to 20 mL of brain, heart infusion (BHI, BD, Franklin Lakes, NJ) media at a 
starting optical density of 0.12.  The culture was incubated at 37° C for approximately 
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five hours until the O.D. reached 0.25, which corresponded to 108 bacteria per mL.  
Bacteria were washed in sterile PBS and resuspended in phagocytosis buffer. R. equi 
were diluted to 75 µg/mL in PBS in a 1 mL microcentrifuge tube and then placed in a 
heat block for 90 minutes and held at 75° C for 90 minutes to kill the bacteria.  To 
confirm killing occurred, a sample was streaked onto a BHI plate at 37° C, 5% CO2 and 
incubated for 48-72 hours to confirm that no growth occurred following the heat-kill 
procedure.  The killed bacteria were then further diluted to 1 µg/mL.  A total of 5 µg of 
the heat killed R. equi diluted in sterile PBS was used each time during pulmonary 
immunogen instillation to the right side of the lung. 
 
Bronchoalveolar Lavage 
Bronchoalveolar lavage fluid (BALF) was obtained from the neonatal period 
through adulthood.  BAL were performed on day zero (d0), day one (d1), and day four 
(d4) beginning at week one (w1), week four (w4), week eight (w8), week 26 (w26) and 
week 52 (w52) of age.  BALF was always collected from the left lung first; then PBS was 
instilled as the control.  The endoscope was then moved to the right side of the lung, for 
BALF collection.  Prior to removing the endoscope from the right side of the lung 
immunogen was instilled (5 µg of heat-killed R. equi) on day 0 after each week time 
point.  The BAL was performed as previously described [8].  The lavage was performed 
using an endoscope appropriate to age and size of the animal with 60 mL syringes 
containing sterile saline.  After insertion of the endoscope into the elected site, BALF was 
harvested in syringes by aspiration of the instilled saline.  
A small amount of clarified BALF was aliquoted and frozen at -20° C for ELISA 
cytokine analysis and an EDTA tube containing 1 mL of BALF was sent for cell count 
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and cytology as in Hostetter et al., 2017 (Appendix) [9].  Remaining fluid was placed into 
50 mL conical tubes and centrifuged at 500 x g for 10 minutes at 4° C.  Pellets were 
washed using DPBS (Mediatech, CellGro, Inc., Manassas, VA) containing decreasing 
amounts antibiotic/antimycotic (Lonza, Basel Switzerland) (wash 1: 2.5 µg amphotericin-
b/ml; wash 2: 0.1 µg amphotericin-b/mL, 2 U of penicillin/ml, and 2 U streptomycin/ml).  
Cells were pelleted after the second wash and resuspended in freezing medium containing 
90% fetal bovine serum (FBS) (Atlanta Biologicals Inc., Flowery Branch, FL) and 10% 
DMSO (Sigma-Aldrich, St. Louis, MO).  Cells were placed in an isopropanol Mr. 
Frosty® (Nalgene, Rochester, NY) freezing container at -80° C for 24-72 hours prior to 
transfer to liquid nitrogen. 
 
Cytokine Measurement 
To characterize the pulmonary cytokine environment, ELISAs were performed on 
BALF.  BALF was analyzed for equine IL-4 and TNF-α using R&D Duo-Set ELISA Kits 
(R&D Systems, Minneapolis, MN).  The assay standard concentration range for both IL-
4 and TNF- α was 31.3 pg/mL - 2,000 pg/mL.  Samples were run neat (BALF as 
collected), and in triplicates. Absorbance was measured using FLUOstar® Omega (BMG 
Labtech, Cary, NC) fluorimeter at 425 nm.  Optical density values were converted to 
pg/mL using a 4-parameter fit function using the Omega software.  Ratios of TNF-α:IL-4 
were created for cytokine normalization of data. 
 
Statistical Analysis 
Data were analyzed with the statistical software package SAS (version 9.4, SAS 
Institute Inc., Cary, NC).  The concentration of cytokines and the ratio of the 
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concentration of cytokines in the BAL were log10-transformed prior to statistical analysis 
to ensure normally distributed residuals.  Data were analyzed by using the MIXED 
procedure of SAS (SAS Institute Inc., Cary, NC) as a split-plot -in- time design with 
repeated measures with foal as the whole-plot and foal age as the sub-plot.  “Foal” was 
considered random and “day relative to heat-killed R. equi exposure” was a repeated 
measure.  To calculate changes in cytokine concentration relative to day 0, the difference 
between the cytokine concentration and the concentration on day 0 was found for both 
days 1 and 4.  A constant was added to each value to eliminate negative numbers prior to 
log10-transformation.  After statistical comparisons were made, the values were back-
transformed and the constant was subtracted from the back-transformed data. All data 
presented are LSMeans and SEM following back-transformation.  Mean separations were 
protected by an overall F-test and differences were considered significant when p < 0.05.  
Data and significant values for the TNCC and cellular proportions is being reported from 
Hostetter et al. 2017 (Appendix) [9]. 
 
Results  
 
BALF Cell Proportions and Total Nucleated Cell Count (TNCC) Changed as Foals 
Age 
The cellular proportions of the BALF fluid analyzed from foals significantly 
changed across the first year of age.  Foals less than eight weeks of age had the highest 
proportion of macrophages compared to 26-week-old and 52-week-old horses (Figure 2-
1).  Interestingly, foals aged 26 weeks and greater had higher proportions of lymphocytes 
when compared to younger foals (Figure 2-1). 
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Foals Had Increased IL-4 Concentrations within BALF Early in Life While BALF 
TNF-α Concentrations Did Not Change During the First Year of Life 
Foals exhibited higher concentrations of IL-4 in the BALF at time points ≤ six 
months of age compared to that measured at one year of life (Figure 2-2).  Furthermore, 
the baseline concentration of IL-4 increased from one week to four weeks of age and 
either exhibited similar concentrations or a slightly higher concentration by eight weeks 
of age.  Around 26 weeks (six months of age), the concentration of IL-4 significantly 
decreased and was also low at one year of age (Figure 2-2).  Foals had significantly 
greater IL-4 concentrations during week one compared to six months of age (p < 0.0015) 
(Figure 2-2).  At four weeks of age, the BALF IL-4 concentration was significantly 
greater than weeks 26 and 52 (p < 0.0005) (p < 0.025, respectively) (Figure 2-2).  By 
eight weeks of age, the BALF IL-4 concentration of foals was significantly greater than 
six months of age (p < 0.003) (Figure 2-2) and was significantly less than 52 weeks of 
age within the left side of the lung (p < 0.0467) (Figure 2-2B).  Furthermore, this pattern 
was largely consistent for both the right and left sides of the lungs, which were sampled, 
processed, and analyzed separately.  In contrast, BALF concentrations of TNF-α did not 
significantly change as the foal aged and this consistency was present in both the right 
and left lungs (p > 0.05; Figure 2-3).   
 
The Foal Ratio of IL-4:TNF-α Significantly Changed During the First Year of Life 
In order to normalize the cytokine concentrations and account for any minor 
changes of volume differences between lung sides during the BAL procedure, the mean 
of the right and left cytokine values on day 0 for each foal respective of the age of the 
regulatory/tissue repair cytokine, IL-4 was divided by the mean of the pro-inflammatory 
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cytokine, TNF-α, to determine changes relative to each other.  The ratio significantly 
changed (p < 0.05) (Figure 2-4) as the foals aged but the difference was primarily driven 
by changes within IL-4 BALF concentrations (Figure 2-2) as there were no statistically 
significant differences in BALF TNF-α concentrations as the foals aged (Figure 2-3).  
Early in life, the ratio was a lower number, and this was due to the relatively higher 
concentration of IL-4 compared to the lower IL-4 concentration measured later in life 
(Figure 2-4).  By six months of age, the ratio markedly increased, and this is due to a 
dramatic decrease in IL-4 concentration (Figure 2-2, Figure 2-4).   
 
The Pattern of Cytokine Response in Foals to Pulmonary Instillation of Heat-Killed 
R. equi vs. PBS Changed During the First Year of Life 
In order to determine if there were immune response differences in the local 
pulmonary cytokine profile in neonatal foals during the first year of their life, immunogen 
(heat-killed R. equi (5 µg)) was instilled into the right lung and PBS was instilled into the 
left lung.  BALF was collected one day and four days post-instillation.  During early life 
(less than two months of age) within the right lung, BALF IL-4 significantly increased in 
response to heat-killed R. equi during w1 and w8 of life (p < 0.05) (Figure 2-5).   
Of note, BALF IL-4 concentrations were observed at their highest concentration 
during week four (Figure 2-2) yet, the BALF concentration of IL-4 decreased in response 
to R. equi which may suggest either the maximal pulmonary secretion level of cytokines 
or a sensitivity limit of the ELISA detection range.  Following week eight, virtually no 
differences regarding response to antigen were observed.   Concerning the control lung 
(left lung), no significant three-way interaction between age, week, and day occurred 
(Figure 2-5) (p > 0.05).  There were minor changes in the BALF IL-4 concentration on 
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the left side of the lung during day 1 and day 4 post-instillation; however, the magnitude 
of these changes was less when compared to the right side and no significant difference 
was observed.  According to the F-test, there was no significant interaction between day 
and response to R. equi within the right lung BALF (data not shown) for TNF-α 
concentrations. 
 
Discussion 
This study compared the cytokine milieu, specifically IL-4 and TNF-α, within the 
BALF collected from a cohort of healthy foals.  Additionally, this is the first study to 
assess age-related changes of the pulmonary cytokine milieu within the same cohort of 
foals during their first year of life.  Our results indicate that foals contain higher 
concentrations of baseline BALF IL-4 concentrations earlier in life.  Additionally, the 
local pulmonary cellular population responds differently to instilled antigen earlier in life 
by producing increased concentrations of IL-4.  Interestingly, the concentrations of TNF-
α do not change as a result of age.  These data indicate that the pulmonary immune 
environment of the foal may be either biased toward an anti-inflammatory or regulatory 
immune environment which may impact the surrounding pulmonary alveolar macrophage 
population by influencing their phenotype to adopt an anti-inflammatory and tissue 
repair/regulatory phenotype.  Therefore, as a microbicidal phenotype is not elicited, 
efficient intracellular-killing of macrophage-tropic organisms does not occur.  Overall, 
these results reveal a possible cause for an increased susceptibility to pneumonia caused 
by R. equi within foals.   
Interleukin-4 is a primary Th2 regulatory, and tissue repair cytokine that is 
produced by a variety of immune cells including lymphocytes, basophils, and eosinophils 
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and is most regarded for its immune physiologic role during parasitic infections, antibody 
production and class switching of B-cells following vaccination, as well as its aberrant 
role during allergic diseases [10].  As an equally important function, though less 
promulgated, IL-4 also serves as an important factor in maintaining metabolic 
homeostasis and interest in this area of research is increasing [11].  Production of IL-4 is 
not limited to immune cells and can also be produced by a variety of others including 
bronchial epithelial cells [12, 13].  Interestingly, a study demonstrating that human 
bronchial epithelial cells produce IL-4 suggested that IL-4 set up an anti-inflammatory 
environment within the pulmonary system [14].  Furthermore, IL-4 inhibits both the 
trafficking of CD4+ T cells that secrete IFN-γ and the overall polarization of T cells to a 
Th1 or pro-inflammatory phenotype [15].  The overall anti-inflammatory environment 
created by IL-4 coupled with this cytokine’s potential suppression of Th1 cell recruitment 
could dramatically alter the resident pulmonary alveolar macrophages’ phenotype and 
enhance macrophage susceptibility to become infected by R. equi while decreasing 
macrophage functionality through dampened production of reactive oxygen 
intermediates.  
Given that IL-4 concentrations present within foal BALF significantly decreased 
as the foals aged, it would not be unreasonable to presume that IL-4 has a particularly 
important role in tissue development during the growth of a young animal while 
providing the initial regulatory control system for an immature organism encountering 
immense amounts of new antigens and immunogens on a daily basis.  Both normal 
growth and mild inflammation as a result of daily exposure to particulate matter or 
antigen load encountered during the typical life of a newborn causes the need for tissue 
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repair [16].  The exact reason for an increase in IL-4 concentrations within BALF 
collected from foals remains unclear. 
Of note, in the response to instilled heat-killed R. equi in young foals, BALF IL-4 
concentrations also increased, if higher concentrations were not already present.  Initially, 
the BALF IL-4 concentration significantly increased in response to immunogen (w1 and 
w8) but this differential expression pattern is absent in foals greater than six months of 
age which either suggests that foal pulmonary immune responses become more adult-like 
at six months of age, or, rather, additional optimization of immunogen instillation is 
needed.  The need to determine the source of IL-4, both the baseline concentration of 
BALF IL-4 as well as the cellular source creating the increased concentrations of IL-4 
occurring in response to heat-killed R. equi, is important to ascertain in order to identify 
if baseline compared to production of IL-4 following instillation of heat-killed R. equi 
arise from the same cell type as the source of these may be different.  Determining both 
the cell type that is responsible for production of  the baseline BALF IL-4  and the 
concentrations of BALF IL-4 following immunogen instillation are also important to 
understand the immunologic mechanism behind these initial and compensatory responses 
as they may not be secreted by the same cellular source.   
The cellular composition of BALF was studied by Hostetter et al. 2017 
(Appendix) and percentages of macrophages were significantly higher in younger foals 
[9].  Furthermore, there was a significant progressive decrease in the percentage of 
macrophages in BALF with a simultaneous progressive increase in the percentages of 
lymphocytes present within the BALF (Figure 2-1).  Additionally, the percentages of 
neutrophils decreased; however, this trend was not significant.  The population of 
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eosinophils and mast cells, both of which secrete IL-4, were characterized and were 
present at a very low proportion in foals less than two months of age.  Over time, a trend 
was present of increasing percentages of mast cells and eosinophils; however, the data 
were not significant.  Comparison of the cellular composition in concert with the cytokine 
changes is interesting.  The primary IL-4 producing cells, i.e., lymphocytes, eosinophils 
and mast cells, were all at markedly low percentages within foals less than two months of 
age.  These cellular proportion data suggest that the IL-4 BALF concentration is not 
being produced by lymphocytes, eosinophils or mast cells; and the source or sources of 
IL-4 remains unclear.  Additional studies are needed to further test this notion.   
Basophils are also potent producers of IL-4 and have been detected within the 
peripheral blood of neonatal foals [17]; however, they were not observed within the 
pulmonary cellular populations [9].  In BALF collected from piglets, basophils only 
comprised 0-1% of the cellular population [18].  Another potential source of IL-4 is the 
bronchial epithelial cells [12]; however, IL-4 expression by respiratory epithelial cells has 
not yet been investigated in horses.    
Although age-related changes in IL-4 were observed, TNF-α concentrations did 
not change as a result of age.  TNF-α is a potent pro-inflammatory cytokine and is 
produced chiefly by classically activated macrophages.  However, unless warranted by 
invading pathogens, this cytokine should not be overexpressed at the risk of producing 
extraneous systemic inflammatory consequences.  Given that the BALF was collected 
from healthy foals, the consistency of the TNF-α concentrations are not surprising.  
However, what is interesting is the increased macrophage percentage early in life coupled 
with a progressive decrease in this population proportion.   
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A potential reason for consistent BALF TNF- α concentrations in the face of a 
decreasing macrophage population, could be the changing phenotype of macrophages and 
potential epigenetic changes of pro-inflammatory genes.  Early in life, high numbers of 
macrophages are exposed to increased concentrations of IL-4 which likely induce a 
regulatory macrophage phenotype.  As the macrophage proportion decreases, the 
concentration of BALF IL-4 also decreases while the percentage of lymphocytes 
increases.  Therefore, it is not unreasonable to speculate that the population of 
macrophages from foals greater than six months old is more capable of assuming a 
classically activated macrophage phenotype.  Without knowing how the baseline 
concentration of BALF IL-12 and IFN-γ and how they change over time, the exposure of 
macrophages to pro-inflammatory cytokines other than TNF-α in unknown.  Several 
possibilities exist that may explain the neonates bias toward an anti-inflammatory 
environment.  Examples include decreased expression of pro-inflammatory receptors, 
hypermethylation of pro-inflammatory cytokine gene regions, or other epigenetic changes 
[16].  Overall, the BALF TNF-α concentration, particularly in response to immunogen, 
should be further investigated and compared to the concentration within adults.   
In conclusion, this study demonstrated decreasing concentrations of IL-4 within 
the BALF of aging foals from the same cohort while TNF-α concentrations remained 
consistent.  The cause for these age-related changes remains unknown warranting further 
investigation.   Furthermore, a complete profile of cytokines including IFN-γ, IL-10, IL-
13, IL-5, IL-6, IL-12 and IL-1β would enhance the understanding of the broader scope of 
the cytokine milieu in the lungs of aging foals.  Nonetheless, these findings demonstrate 
higher baseline concentrations of IL-4 contained within foal BALF when compared to a 
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year of life.  Furthermore, in response to pulmonary immunogen instillation, a pattern of 
increased IL-4 concentrations was observed in foals aged one- and eight- weeks-old in 
comparison to foals older than six months.  This response in young foals exposed to 
immunogen provides insight for the well documented increased susceptibility of 
pneumonia in foals caused by R. equi.   
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Figures 
 
 
 
Figure 2-1. Age-related changes in the proportion of the total nucleated cell count 
from BALF during the first year of life in the foal.  Higher TNCC counts for foals 
were observed at one week (median: 320/µL), four weeks (median: 230/µL), eight weeks 
(median: 340/µL), 26 weeks (median: 285/µL), and 52 weeks (median: 205/µL).  
Temporal changes in percentages of macrophages (lavender), lymphocytes (orange), 
neutrophils (mauve), eosinophils (light grey), and mast cells (dark grey) were observed in 
bronchoalveolar lavage fluid (BALF) samples taken from horses at various ages.  Horses 
at four (*) weeks of age had a significantly higher percentage of macrophages than 52 
(**) week -old horses (lavender; **p < 0.05).  The lymphocyte percentage was lowest in 
horses aged one week (^) and differed significantly from 52 (^^)- and 26 (^^)-week-old 
horses (orange; (**p < 0.0005; ***p < 0.01, respectively).  Horses aged four weeks (^) 
also had a significantly lower percentage of lymphocytes than horses aged 52 (^^) weeks 
(orange; **p < 0.01).  Foals at one week of age had a higher median percentage of 
neutrophils than other age groups; however, this finding was not statistically significant 
(mauve). Horses at 26 weeks of age had a significantly higher percentage of eosinophils 
than horses aged one week and four weeks (light grey; p < 0.01, p <0.05, respectively).  
Mast cells (dark grey) tended to increase over the first year of life although this trend was 
not significant.  No plasma cells (green) were observed during the first year of life.  Data 
are expressed as percentages of TNCC value (One-way ANOVA with Dunn’s test for 
multiple comparisons).  Figure created using modified data from Hostetter et al., 2017 
(Appendix) [9].  
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Figure 2-2. Foals have significantly greater concentrations of interleukin 4 within 
BALF at a young age.  BALF was sampled from both the left (A) and right (B) lungs of 
aging foals and measured for baseline pulmonary concentrations of IL-4.  IL-4 was 
measured by ELISA according to kit instructions (R&D Systems, Minneapolis, Mn).  
BALF samples were tested neat and run in triplicates; absorbance was measured at 450 
nm using a fluorimeter and plotted along a 4-paramteter standard curve fit.  The average 
concentration of IL-4 was found at each time point; the data were not normally 
distributed requiring a log-transformation.  Data are plotted as back-transformed, 
normalized concentration values.  Statistics were performed using the log-transformed 
data in an F-protected MIXED Model.  Log-transformed significant differences observed 
within the left lung (A) are as follows: week 1 vs. week 26 (p = 0.0012; SEM = 0.43); 
week 4 vs. 26 (p = 0.0002, SEM = 0.44) and 52 (p = 0.021, SEM = 0.51); and week 8 vs. 
week 26 (p=0.0007, SEM= 0.44) and week 52 (p=0.0467, SEM= 0.51).  Log-transformed 
significant differences observed within the right lung (B) are as follows: week 1 vs. week 
26 (p = 0.0008, SEM = 0.46); week 4 vs. 26 (p = 0.0004, SEM = 0.47) and 52 (p = 
0.0093, SEM = 0.54), and week 8 vs. week 26 (p = 0.0027, SEM = 0.47).  Sample 
numbers are as follows: week 1, n = 7; week 4, n = 6; week 8, n = 6; week 26, n = 6; and 
week 52, n = 4.  
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Figure 2-3. Changes of BALF TNF-α concentrations are not affected by the age of 
foal.  BALF was sampled from both the left lungs (A) and right (B) lungs of aging foals 
and measured for baseline pulmonary concentrations of TNF-α.  TNF-α was measured by 
ELISA according to kit instructions (R&D, Minneapolis, Mn).  BALF samples were 
tested neat and run in triplicates; absorbance was measured at 450 nm using a fluorimeter 
and plotted along a 4-paramteter standard curve fit.  Data are plotted as back-
transformed, normalized concentration values.  Statistics were performed using the log-
transformed data in an F-protected MIXED Model.  No significant differences in TNF-α 
levels are observed during the first year of life of the foal (p > 0.05 at each time point).   
Sample numbers are as follows: week 1, n = 7; week 4, n = 6; week 8, n = 6; week 26, n 
= 6; and week 52, n = 4. 
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Figure 2-4. The TNF-α:IL-4 ratio significantly changed with age.  Cytokines from 
BALF from the left lung (A) and right lung (B) were measured by ELISA according to 
kit instructions (R&D Systems, Minneapolis, Mn).  BALF samples were tested neat and 
run in triplicates; absorbance was measured at 450 nm using a fluorimeter and plotted 
along a 4-paramteter standard curve fit.  In order to normalize cytokines, a ratio was 
made between the pro-inflammatory cytokine, TNF-α and the regulatory/tissue repair 
cytokine IL-4.  The change in the ratio across the first year of life is driven primarily by 
changes in IL-4 levels which ultimately decrease with age causing an increase in the 
TNF-α/IL-4 ratio at six months of age.  The ratio of TNF-α:IL-4 was determined for each 
foal, and the ratios were then averaged, log-transformed and statistically analyzed.  Data 
are plotted as back-transformed, normalized ratio values.  Statistics were performed using 
the log-transformed data in an F-protected MIXED Model.  Log-transformed significant 
differences observed within the left lung rations (A) are as follows: week 1 vs. week 26 
(p = 0.0039; SEM = 0.44), week 4 vs. 26 (p < 0.0001; SEM = 0.45) and 52 (p = 0.0098; 
SEM = 0.51); and week 8 vs. week 26 (p = 0.00287; SEM = 0.45).  Log-transformed 
significant differences observed within the right lung ratios (B) are as follows: week 1 vs. 
week 26 (p = 0.0008; SEM = 0.45), week 4 vs. 26 (p < 0.0001; SEM = 0.47) and 52 (p = 
0.006; SEM = 0.53), and week 8 vs. week 26 (p = 0.0084; SEM = 0.47).  Sample 
numbers are as follows: week 1, n = 7; week 4, n = 6; week 8, n = 6; week 26, n = 6; and 
week 52, n = 4. 
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Figure 2-5. The IL-4 concentration response to heat-killed Rhodococcus equi  vs. 
PBS pulmonary instillation is significantly different with age.  Cytokines were 
measured by ELISA according to kit instructions (R&D, Minneapolis, Mn).  BALF 
samples were tested neat and run in triplicates; absorbance was measured at 450 nm using 
a fluorimeter and plotted along a 4-paramteter standard curve fit.  A difference between 
day 0 and day 1 was created by subtracting day 0 BALF IL-4 concentrations by day 1 
BALF IL-4concentrations or day 4 BALF IL-4 concentrations for the left lung (A) and 
right lung (B).  A positive bar represents an increase in the cytokine while a negative bar 
represents a decrease.  Significant differences are present only in the right lung which 
received the pulmonary instilled immunogen of heat-killed R. equi (immunogen).  During 
week 1, IL-4 concentrations on day 0 vs. day 4 are significantly different from each other 
and demonstrate a large increase in IL-4 concentrations in response to immunogen (p = 
0.0021; SEM = 1.173).  During week 4, the change in IL-4 from day 0 to day 1 
demonstrates a significant decrease in IL-4 (p = 0.048; SEM = 1.19).  During week 8, day 
0 vs. day 4 demonstrates a significant increase in IL-4 in response to immunogen (p = 
0.0492; SEM = 1.19).  Sample numbers are as follows: week 1, n= 7; week 4, n=6, week 
8, n=6; week 26, n=6, and week 52, n=4. 
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Abstract  
Pneumonia is a predominant cause of morbidity and mortality in foals less than 6 
months of age; however, adult horses, unless immunocompromised, are not as susceptible 
to pneumonia caused by Rhodococcus equi .   An inciting factor for the age-related 
susceptibility may be the extent to which microbicidal activity exists in neonatal 
pulmonary alveolar macrophages (PAM) and how these respective PAM are activated.  A 
lack of effective production of nitric oxide and peroxynitrite by alveolar macrophages has 
been documented in severe early-onset neonatal pneumonia, indicating a defect in 
fundamental lung defense mechanisms during this developmental period.  Given the 
differing pulmonary cytokine milieu between the neonate and adult horse, we speculate 
that macrophage phenotype is impacted by the cytokine milieu imparting varying degrees 
of microbicidal activity in pulmonary alveolar macrophages (PAM) and monocyte 
derived macrophages (MDM).  To test this hypothesis, following sample collection, 
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peripheral blood mononuclear cells (PBMC) were cultured in vitro to form MDM.  Then, 
MDM and PAM were isolated from aging foals and then stimulated and infected in vitro 
with R. equi.  Consistent with our hypothesis, in vitro infected MDM and PAM derived 
from foals yielded a higher bacterial load than in adults.  Additionally, macrophages 
derived from foals exhibited lower concentrations of peroxynitrite and superoxide 
production as compared to the adult.  Cytokine profiles, including interleukin-4 (IL-4), 
interleukin-10 (IL-10), and interferon-gamma (IFN-γ) from stimulated PAM, were 
characterized by flow cytometry and yielded significant differences.  The concentration 
of intracellular IL-4 and IFN-γ in stimulated foal PAM was greater from older foals than 
younger foals.  However, stimulated PAM had a relative decrease in IL-10 production 
and a relative increase in IFN-γ and IL-4 production with age.  Related to extrinsic 
factors directly affecting macrophage activation, CD154 (CD40L) is expressed on 
activated lymphocytes and functions as a co-stimulatory molecule that activates antigen 
presenting cells, along with cytokines and the T cell receptor interacting with the antigen 
being presented by the antigen presenting cell, like macrophages.  CD154 was 
investigated and foal lymphocytes express less CD154 when compared to adult 
lymphocytes.  Taken together, these critical differences indicate that foal macrophages 
are more susceptible to infection with R. equi and support the notion that the cytokine 
milieu impacts the ability of macrophages to employ a microbicidal response.  
 
Introduction 
Rhodococcus equi  (R. equi) is a gram-positive coccobacillus bacteria that is a 
facultative intracellular pathogen that is phylogenetically similar to Mycobacterium 
tuberculosis causing disease in horses less than 6 months of age [1].  This bacterial 
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pathogen primarily causes respiratory disease in the form of chronic pyogranulomatous 
bronchopneumonia that is characterized by excessive abscessation; however, the disease 
may also occur within the enteric system where it is associated with ulcerative 
enterocolitis and typhlitis.  Extrapulmonary disorders are common sequelae to R. equi 
infection and include other physiologic systems such as abscessation within the 
peritoneal cavity as well as immune-complex formation causing non-septic polysynovitis 
of the joints [1-3].   
R. equi is ubiquitous in the farm environment, living within soil, replicating in 
manure, and readily being aerosolized in dust particles [4, 5].  Once the microbe gains 
entry into the lungs, it is readily phagocytized by pulmonary alveolar macrophages 
(PAM) but prevents maturation of the phagolysosome through its virulence plasmid, 
VapA [2, 3].  Once phagocytized, R. equi specifically avoids intracellular killing by the 
PAM through disrupting lysosome reformation; thereafter, the microbe replicates and 
causes massive inflammation [6].  As a result of the co-evolutionary relationship between 
the equine species and this bacterial species, R. equi is able to preferentially proliferate in 
foal pulmonary macrophages but not in adult equine macrophages, and this susceptibility 
is related to foundational immunologic differences between the foal and the adult.  
A spectrum of macrophage phenotypes is recognized, and three main phenotypes 
are acknowledged: classically activated, wound healing, and regulatory macrophages.  
Interestingly, activated macrophages may be biased toward a regulatory or wound healing 
phenotype in neonatal foals [7, 8].  Classically activated macrophages are needed to 
combat R. equi infection due to their enhanced bactericidal functions such as the ability 
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to produce reactive oxygen (ROS) and nitrogen species (RONS) after engulfment of the 
microbe within the phagolysosome.   
Professional phagocytes like macrophages produce several enzymes that, once 
assembled, translocate to the cellular membrane in order to catalyze highly reactive 
intermediates that possess antimicrobial activity [9].  Specifically, the NADPH phagocyte 
oxidase and nitric oxide synthase pathways are paramount for the production of 
superoxide and nitric oxide radicals, respectively.  The reaction between superoxide and 
nitric oxide can form the highly reactive peroxynitrite which has broad anti-microbial 
activity that is crucial to microbicidal functions of classically activated macrophages [10] 
[11].  It has been demonstrated that cytokines and ligation of Toll-like receptors (TLR) 
can influence activation of macrophages and the subsequent production of reactive 
intermediates.  In addition, ligation of TLRs can induce the expression of pro-
inflammatory cytokines such as interferon gamma (IFN-γ) and tumor necrosis  
factor-alpha (TNF-α) by macrophages [2].  Therefore, our central hypothesis is that 
equine neonatal pulmonary alveolar macrophages produce fewer ROS and RONS due to 
altered macrophage activation by the pulmonary cytokine milieu of the neonatal lung.   
 
Materials and Methods 
Animals 
Twelve healthy foals were sampled at one week, one month, six months, and 12 
months of age for bronchoalveolar lavage fluid (BALF) and peripheral whole blood 
dissolved in sodium citrate.  Samples were also taken from three adult geldings, greater 
than or equal to six years of age, or the mare of the corresponding foal.  
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Cell Harvest and Isolation 
The bronchoalveolar lavage fluid (BALF) was collected by endoscopy using 
previously published techniques that were also approved by the Institutional Animal Care 
and Use Committee of Iowa State University [12].  A sample of the BALF was submitted 
to the Clinical Pathology Department at Iowa State University’s College of Veterinary 
Medicine for assessment of cell populations.  After collection, BALF was centrifuged at 
500 x g for 30 minutes at 4° C to pellet the cellular population.   
PBMC were isolated from the whole blood collected using a centrifugation 
technique by layering buffy coats onto a double density gradient of Histopaque-1077 and 
-1119 (Sigma-Aldrich, St. Louis, MO).  This technique isolated the peripheral blood 
mononuclear cell (PBMC) population and removed granulocytes and erythrocytes from 
the fractions.  Both BALF and PBMC cellular isolates were subsequently aliquoted into 
cryovials in 90% fetal bovine serum (FBS) (Atlanta Biologics, Flowery Branch, FL) and 
10% DMSO (Sigma-Aldrich, St. Louis, MO) and stored in liquid nitrogen for future use.  
Before each experiment, aliquots from BALF and blood were thawed in 37° C water 
bath, suspended in 100% FBS (Atlanta Biologics, Flowery Branch, FL), centrifuged and 
immediately prepared for flow cytometry, or in vitro infection with subsequent reactive 
oxygen intermediate fluorimetry. 
 
Cell Sorting 
Cells from PBMC and BALF were isolated from peripheral blood and BALF, 
suspended in 90% FBS (Atlanta Biologics, Flowery Branch, FL) and 10% DMSO and 
stored in liquid nitrogen until analysis.  The BALF cells were then removed from liquid 
nitrogen, thawed in a 37° C water bath for < 5 minutes, resuspended in Dulbecco’s 
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Modified Eagle Medium (DMEM) (Mediatech, CellGro, Manassas, VA) with 1 g/L of 
glucose, L-glutamine, and sodium pyruvate without phenol red, 20% FBS (Atlanta 
Biologics, Flowery Branch, FL) and penicillin/streptomycin/amphotericin-B (P/S/AmpB) 
(Lonza, Basel Switzerland), and immediately centrifuged (500 x g for 10 minutes at 4° 
C).  Pelleted cells were then resuspended in PBS with 0.5% bovine serum albumin and 2 
mM EDTA (FACS buffer) and stained with anti-CD172a antibody (VMRD 
DH59B/equine CD172a, Pullman, WA) and with a secondary anti-IgG-FITC antibody 
(AbD Serotec, Bio-Rad Laboratories, Hercules, CA).  CD172a+ live cells [13] were gated 
and sorted from the remaining cellular populations for infection and fluorimetry 
experiments and are referred to as MDM and PAM CD172a+ cells for the remainder of 
this chapter.   
 
Intracellular-Bacterial Killing 
PAM from either foals at week one of age (n=3) and adults (n=3) were seeded 
onto a 96-well clear-bottom black plate at a density of 1 x 105 cells/well and incubated 
for 24 hours at 37° C + 5% CO2 in 100 µL of DMEM + 20% heat inactivated FBS and 
P/S/AmpB.  Plates were then stimulated with 10 ng/mL of recombinant equine IFN-γ 
(reIFN-γ) (R&D Systems; Minneapolis, MN) in order to activate the macrophage 
enabling production of reactive intermediates for 24 hours [14].  Media was changed to 
DMEM +20% FBS without antibiotics and reIFN-γ.  MDM and PAM were then infected 
with GFP and dsRed-transformed R. equi obtained from the laboratory of Dr. Bryan 
Bellaire, Iowa State University.  After four hours of infection, media was changed to 
DMEM + 20% FBS + 50 µg/mL gentamicin sulfate (CalBioChem, San Diego, CA) to 
kill any extracellular bacteria that was not phagocytosed.  Preliminary experiments were 
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carried out to ensure that R. equi was killed by gentamicin sulfate through plating the 
supernatant to confirm that no growth occurred.  Infections were carried out for 24, 48 
and 72 hours with media changes every 24 hours.  Relative intracellular bacterial load 
was determined by measuring GFP (485/510) and dsRed (560/580) fluorescence using a 
microtiter plate reader (FLUOStar® Omega, BMG Labtech, Cary, NC).  Production of 
superoxide and peroxynitrite was assessed by indirect fluorescent detection of oxidized 
dihydroethidium (DHE) or dihydrorhodamine (DHR) (Life Technologies, Carlsbad, CA), 
respectively, in the GFP and dsRed infected macrophages, respectively [15].   
 
Cytokine Expression 
Following thawing, PAM (n=3) were stained for CD172a, isolated via flow 
cytometry following live vs. dead and cell size and granularity selections.  CD172a+ cells 
were sorted and seeded into flow tubes at 1 x 106 cells per tube and were subsequently 
stimulated with 0.5 mL of 75 µg/mL heat-killed R. equi for 24 hours.  After stimulation, 
the PAM were fixed, permeabilized and stained for intracellular IL-4, IL-10, and IFN-γ 
(R&D Systems; Minneapolis, MN; VMRD, Pullman, WA).  Flow cytometry data was 
analyzed by measuring the percentage of cells expressing each individual intracellular 
cytokine.   
 
CD154 Expression 
To investigate extrinsic macrophage mechanisms directly influencing macrophage 
activation, CD154 analysis of PBMC was carried out [16, 17].  PBMC from foals (n=3) 
at various time points (week one, month one, month six, month 12) and adult controls 
(n=3) were evaluated for expression of CD154.  Cells were stained with a primary human 
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specific anti-CD154 antibody (Millipore, San Diego, CA, USA) diluted in PBS 
containing 20% FBS (Atlanta Biologics, Flowery Branch, FL) and washed with PBS.  
Then cells were stained with a rabbit F(ab’)2 anti-mouse IgG:FITC secondary antibody 
diluted 1:100 in FACS buffer for FACS analysis.  CD154+ cells were isolated via flow 
cytometry as described above and then seeded into flow tubes at 1 x 106 cells per tube 
and stimulated with 10 ng/ml reIFN-γ for 24 hours.  After stimulation, cells were briefly 
washed with PBS, stained for intensity and percent population of extracellular CD154 
with a human CD154-specific monoclonal mouse antibody (Millipore, San Diego, CA, 
USA) that demonstrated satisfactory cross-reactivity with equine CD154, per 
manufacturer,  and a secondary rabbit anti-mouse IgG:FITC (AbD Serotec, Bio-Rad 
Laboratories, Hercules, CA). Then, cells were fixed with 2% paraformaldehyde for 15 
minutes, washed with 4° C PBS and then resuspended in FACS buffer.  Results are 
presented as mean fluorescence intensity (MFI). 
 
CD154 Stimulation 
Equine monocyte-derived macrophages were sorted for CD172a+ cells as 
described above and were seeded at 1 x 105 cells/well into a 96-well flat bottom plate and 
incubated overnight (37˚ C, 5% CO2) in 100 µl RPMI (Mediatech, CellGro, Manassas, 
VA) containing 20% FBS without phenol red to avoid interference with fluorimetry 
readings.  Plates were then co-cultured for 12 hours with 2,000 CHO cells (ATCC CCL-
61TM expressing ectopic equine CD154 or without ectopic equine CD154 [18]) with or 
without reIFN-γ (10 ng/ml) as a positive control.  DHE and DHR were used as described 
above.  Experiments were performed in replicates of four and repeated. Data are 
presented as mean +/- standard deviation with significance defined as p < 0.05. 
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Statistical Analysis 
Data were analyzed for normality by the Kruskal-Wallis Test. Data were then 
analyzed by either a one-way non-parametric (Wilcoxon Rank Test) or two-way ANOVA 
where applicable with Tukey's HSD post-hoc adjustments, respectively.  Correlations 
between fluorescence of intracellular bacteria and ROS and RONS fluorescence were 
calculated using the Spearman correlation coefficient.  Statistical analysis was performed 
using JMP Pro 11.0 software and SAS/STAT software (SAS Institute Inc., Cary, NC).  
All graphs were generated using GraphPad Prism (GraphPad Software Inc., La Jolla, 
CA).  For all comparisons, p < 0.05 was considered statistically significant.  Within the 
figures, contrasting letters represent statistical significance. 
 
Results 
 
Intracellular Bacterial Killing 
Pulmonary alveolar macrophages (PAM) were sorted from other cells within the 
BALF by their expression of CD172a (Figure 3-S1).  After sorting, PAM were infected 
with R. equi transformed with either dsRed or GFP at a multiplicity of infection (MOI) of 
5:1.  Bacterial load was measured at 24, 48, and 72 hours post-infection (Figure 3-1A) 
and reactive intermediates were measured at 24 hours post-infection (Figure 3-1B1 and 
B2).  Results demonstrated that PAM from foals infected with R. equi had decreased 
production of superoxide and peroxynitrite compared to their adult counterparts (Figure 
3-1B1, p < 0.001 and Figure 3-1B2, p < 0.001).  Also, foal PAM expressed higher levels 
of dsRed or GFP fluorescence indicating higher levels of intracellular bacteria at 48 (p < 
0.01) and 72 hours post-infection (p < 0.001) (Figure 3-1A).  Foal and adult PAM had a 
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similar infective load at 24 hours indicating the internalization of the bacteria occurred at 
a similar rate; however, R. equi was cleared from the adult PAM while it persisted within 
the foal PAM.  An inverse correlation between the production of reactive intermediates 
and bacterial load was observed (p < 0.004) indicating a diminished respiratory burst 
within foal PAM, when compared to the adult, and thus, foal PAM may permit prolonged 
survival of intracellular R. equi (Figure 3-1)   
 
Intracellular Cytokine Expression 
Pulmonary alveolar macrophages from foals stimulated with heat-killed R. equi 
expressed more intracellular IL-10 and less IL-4 and IFN-γ during the first week of life              
(p < 0.05) compared to other age groups (Figure 3-2).  A significant decrease in the 
expression of IL-10 by one month of age was observed (p < 0.001); however, there was 
still diminished expression of IL-4 and IFN-γ by PAM collected at one and six months of 
age compared to PAM collected at 12 months of age (IL-4, p < 0.05; IFN-γ, p < 0.005) 
(Figure 3-2).   
 
CD154 Expression 
Lymphocytes, isolated by size and granularity via flow cytometry (Figure 3-S1), 
from foals less than 12 months of age (week 1, month 1, month 2, and month 6) 
expressed significantly less CD154 (Figure 3-3, p < 0.0001).  Lymphocytes recovered 
from foals aged 12 months had the same level of CD154 expression as their adult 
counterparts (Figure 3-3, p < 0.0001).  There was no significant difference in CD154 
expression on lymphocytes recovered from foals ≤ 6 months of age (week 1, month 1, 
and month 2). 
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CD154 Stimulation 
In order to evaluate the ability of CD154 to stimulate macrophages, PBMC from 
foals within their first week of life and their dams (adult) were isolated, cultured to 
created monocyte-derived macrophages (MDM), and then, stimulated with a CHO cell 
line that had been previously transfected to express equine CD154 (Figure 3-4) [18].  Co-
culture with CD154-expressing CHO cells resulted in an increase in reactive oxygen 
intermediates in adult MDM but did not stimulate foal MDM (Figure 3-4A and 3-4B, p < 
0.05).  Adult MDM produced significantly more superoxide (Figure 3-4A, p < 0.0001) 
when stimulated compared to foals; adults also had higher production of peroxynitrite as 
compared to foals (Figure 3-4B, p < 0.0001). 
 
Discussion 
In this study, we speculated that potential differences in the pulmonary cytokine 
environment within the neonatal vs. adult horse would affect the phenotype and function 
of the resident macrophage population.  Given that foals produce more IL-4 within their 
pulmonary environment (Chapter 2) during their first few months of life, their 
macrophages are presumably biased to a regulatory or anti-inflammatory phenotype 
compared to an enhanced microbicidal phenotype adopted later in life.  Therefore, it 
appears that foal macrophages evolve to a classically activated phenotype as they age 
and, as a result, are less likely to become infected with Rhodococcus equi.  Furthermore, 
foals have a significantly greater percentage of macrophages within their BALF than 
adults whose BALF is predominantly composed of lymphocytes [19].  This 
overrepresentation of macrophages coupled with higher concentration of IL-4 exposure 
likely increases the probability of infection with R. equi.  These conditions create an 
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excellent environment for this macrophage-tropic organism to exploit the host:  increased 
numbers of regulatory/tissue repair macrophages that are less able to produce reactive 
intermediates at adequate levels to kill R. equi.  
To test this hypothesis, foal and adult macrophages were infected with 
transformed R. equi expressing either dsRed or GFP.  Bacterial load was quantified via 
fluorimetry.  Following the foal and adult macrophage R. equi infection incubation 
period, the bacterial load in foal macrophages was significantly greater than when 
compared to adults (Figure 3-1).  This indicates a greater susceptibility for infection 
within the foal macrophages compared to the adult macrophage.  Furthermore, to test the 
hypothesis that foal macrophages produce less ROS and RONS than adults, we measured 
reactive intermediate production from PAM in the foal and the adult after infection with 
R. equi and following in vitro stimulation.   
Interestingly, there was a strong inverse correlation between ROS and RONS 
production and bacterial load for the foal; i.e., the foal macrophages contained a higher 
bacterial load and lower reactive oxygen intermediates simultaneously when compared to 
infected PAM from adults (Figure 3-1).  After 24-48 hours post-infection, the levels of 
superoxide and peroxynitrite were higher in the adult vs. foal macrophages (Figure 3-1B1 
and 3-1B2).  These data demonstrate a reduced functionality, as a result of significantly 
lower levels of reactive intermediates of the foal macrophage.  These observations are 
also consistent with porcine literature.  Dickie et al. 2009 investigated age-related 
changes of pulmonary alveolar macrophages in neonatal pigs and determined that ROS 
production from PAM significantly increased within the first week of life [20].   
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Given that foals contain a greater percentage of macrophages within their BALF 
until six months of life [20], their presumed regulatory phenotype dramatically decreases 
their functionality enabling R. equi to replicate intracellularly and cause pneumonia 
within foals (Chapter 2).  
 To investigate the inherent intracellular cytokine production, macrophages from 
foals and adult horses were isolated via flow cytometry (Figure 3-S1), stimulated with 
heat-killed R. equi and analyzed for presence of intracellular cytokines (Figure 3-2).  
Intracellular cytokine analysis revealed a higher cellular percentage of IFN-γ+ cells 
within the PAM population of adults and older foals, a greater percentage of IL-10+ cells 
within the foal PAM population compared to older foals and adult cells, and a trend of 
increasing IL-4+ cells in aging foals following stimulation with heat-killed R. equi 
(Figure 3-2).  These data from foal PAM are consistent with previously published data on 
foal PBMC.  Wagner et al. determined that foals within the first three months of life were 
virtually incapable of producing IL-4 following foal PBMC stimulation with PMA and 
ionomycin [21] while Breathnach et al. demonstrated that foals were IFN-γ-deficient at 
birth  and that both IFN-γ mRNA expression as well as the secreted protein steadily 
increased throughout the first year of life [22].   
Additionally, and consistent with our previous work demonstrating that PBMC 
from foals produce significantly more IL-10 mRNA than adult PBMC following 
stimulation with LPS or IFN-γ [23], foal PAM also produce more IL-10 than adult PAM 
following stimulation with heat-killed R. equi.  These consistent data are important, 
especially considering the two different cell types (macrophages vs. lymphocytes) and 
varying methods of stimulation, and they ultimately support the notion that macrophages 
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from foals are biased to a regulatory phenotype and thus are less able to adopt 
microbicidal functionality. 
Given the significant differences between the cellular population percentages 
within the lung of foals compared to adults as well as the inherent functional capacity 
difference of the macrophage, directly dependent on age, we wanted to explore whether 
the effects of quantitative differences in populations of cells in the lung could be further 
accentuated by qualitative differences in cell-cell interactions.  We observed age-related 
differences in production of reactive intermediates by macrophages and extended our 
studies by focusing on the CD154/CD40 interaction between macrophages and 
lymphocytes.  Given that lymphocytes activate macrophages during their recognition of 
antigen being presented by the macrophage, we investigated CD154 (CD40L) expression 
of lymphocytes isolated from foals.  Binding of CD154, present on the surface of 
lymphocytes, to CD40 present on antigen presenting cells like macrophages, contributes 
to activation of professional phagocytes [24-26] and is an important innate mechanism of 
defense [18].  As previously demonstrated, without CD154, macrophage-mediated killing 
of both intracellular and extracellular pathogens is markedly diminished [27-29].  To 
characterize CD154 expression within foals and to determine the impact of this particular 
cell to cell interaction between the macrophage and lymphocyte, PBMC from foals and 
adults were isolated and analyzed for CD154 expression.  Not only do foal lymphocytes 
express significantly less CD154 on their surface compared to adults (Figure 3-3), but 
foal macrophages produce significantly less superoxide and peroxynitrite as a result of 
CD154 stimulation when compared to the adult macrophages (Figure 3-4A, and 3-4B, 
respectively).  
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Taken together, the following results indicate that foal macrophages produce 
lower levels of reactive oxygen intermediates which are essential for the clearance of 
intracellular R. equi.  Furthermore, and consistent with other studies, the intracellular 
concentration of intracellular IL-4 and IFN-γ in stimulated foal macrophages was greater 
from older foals than younger foals and the intracellular concentration of IL-10 was 
higher in younger foals [22, 23, 30].  Interestingly, stimulated PAM from older foals had 
a significant decrease in IL-10 production and a relative increase in IFN-γ production 
compared to younger foals.  The influence over macrophage phenotype and functionality 
is multifactorial; however, patterns are present across multiple studies and support the 
notion that foal macrophages are biased to a regulatory phenotype and have a reduced 
capacity for production of reactive intermediates.  Collectively, our results indicate that 
the pulmonary cytokine milieu may impact production of reactive intermediates in 
pulmonary alveolar macrophages conferring an increased susceptibility of the foal to 
infection by R. equi. 
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Figures  
 
 
 
Figure 3-1. Inverse correlation of reactive intermediates and bacterial load in R. 
equi infected macrophages in foals vs. adults.  In order to measure the infection rates 
and production of reactive intermediates, PAM were sorted based on CD172a expression 
and plated at 100,000 cells/well.  Stimulation with and subsequent infection with GFP- or 
dsRed-transformed R. equi at an MOI of 5:1 was performed 24 hours later.  One hour 
prior to fluorimetry readings, dihydroethidium (DHE) and dihydrorhodamine (DHR) was 
added to measure superoxide and peroxynitrite production, respectively.  A kinetic time 
course (data not shown) was conducted and 30 hours +/- 6 hours was determined as the 
optimal level for maximum ROS and RONS production detected by both DHE and DHR. 
Furthermore, no difference between 0 hour and 24 RFU of the initial bacterial load was 
observed. Results revealed a higher production of superoxide and peroxynitrite in adult 
infected PAM vs. foal infected PAM (B1, p < 0.002; B2, p < 0.0001).  Also, foal PAM 
expressed higher levels of dsRed or GFP fluorescence indicating higher levels of 
intracellular bacteria (A, p < 0.002).  A Spearman correlation test was run and 
demonstrated a strong r-value of for DHE vs. bacterial load and a strong r-value for DHR 
vs. bacterial load particularly at 48- and 72-hours post-infection.  Correlation coefficients 
and p-vales for DHE are as follows: (p = 0.1193; r  = 0.493); 48 hours post-infection (p = 
0.0257;    r  = 0.752); and 72 hours post-infection (p = 0.0038; r =.0902).  Correlation 
coefficients and p-values for DHR are as follows:  x 24 hours post-infection (p = 0.0616; 
r = 0.624) (p = 0.0079; r = 0.858); and 72 hours post-infection (p < 0.0001; r = 0.991).  
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Figure 3-2. Macrophages from younger foals express elevated levels of IL-10 and 
decreased levels of IFN-γ and IL-4.  Pulmonary alveolar macrophages sorted by 
CD172a selection were seeded into FACS tubes at 1 x 106 cells/tube and stimulated with 
0.5 mL of 75 µg/mL of heat-killed R. equi antigen.  After 24 hours cells were fixed, 
permeabilized and stained for intracellular IFN-γ, IL-4 and IL-10.  Results are expressed 
as the percentage of cells positive for each cytokine.  PAM express more IL-10 and less 
IL-4 and IFN-γ during the first week of life   (p < 0.01).  There is a decrease in the 
expression of IL-10 by month 1; however, there is still diminished expression of IL-4 and 
IFN-γ in foal PAM at month 1 of age compared to month 6 and month 12 (p < 0.05). 
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Figure 3-3. Lymphocytes from foals less than twelve months of age express 
significantly less CD154 compared to adult lymphocytes. PBMC from foals from 
various time points and three adult controls were seeded into FACS tubes at 1 x 106 
cells/tube and stimulated with equine reIFN-γ overnight.  Cells were stained with primary 
mouse anti-human-CD154 antibodies and a secondary rabbit anti-mouse FITC antibody 
and then fixed with 2% paraformaldehyde.  Lymphocytes were gated based on size 
according to Figure 3-S1.  The graph above shows the mean fluorescence intensity of the 
lymphocyte gated cells representing the CD154 positive lymphocytes.  There is a 
significant increase in the CD154 expression at month 12 of age (p < 0.0001) which is 
comparable to adult CD154 expression levels. 
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Figure 3-4. Macrophages from foals stimulated with CD154 expressing cells display 
diminished production of reactive intermediates in comparison with their adult 
counterparts.  Monocyte-derived macrophages sorted by CD172a+ were selected from 
foals less than 1 week of age and adults (the dams of each foal) were cocultured with 
CHO cells that were either expressing the ectopic equine CD154 (stim) or were not 
expressing the ectopic equine CD154 (no stim).  Cells were considered stimulated cells if 
were from co-cultured with equine ectopic CD154 expressing CHO cells, and non-
stimulated cells were those co-cultured with CHO cells that did not express CD154.  
Dihydroethidium (detecting superoxide) and dihydrorhodamine (detecting peroxynitrite) 
were used to measure reactive intermediate response.  Foals displayed lowered 
production of reactive intermediate with or without stimulation with CD154 expressing 
CHO cells compared to their adult counterparts (p < 0.0001). 
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Supplemental Figure 3-S1. Efficient purification of macrophages from PBMC and 
BALF cellular populations using a CD172a sorting protocol via flow cytometry.  
PBMC and BALF-derived PAM were removed from liquid nitrogen and immediately 
thawed.  PBMC were cultured overnight to form MDM. Then MDM and PAM cells were 
then stained with anti-CD172a antibody and with a secondary rabbit anti-mouse IgG-
FITC antibody.  Single cells were selected based on the P1 gate (top left).  Dead cells and 
debris were removed (top right) from the population and the remaining live cells were 
gated based on size and granularity (bottom left) similar to cells of monocyte lineage 
(green population).  Finally, cells were gated based on their expression of CD172a+ 
(green population in bottom left).  Cells that met all three gating parameters were sorted 
and kept for testing (bottom right).  The same gating strategy was used for macrophages 
within the PBMC and BALF cellular populations.  Approximately 20% of the cells in the 
original population were CD172a+ for MDM and 80% for PAM, respectively.  
Lymphocytes (pink population) were negatively selected using the same gating strategy 
but were CD172-.  
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Abstract 
While antimicrobial drugs remain the most common approach for treatment of 
intracellular infections, the increasing emergence of multidrug-resistant-organisms 
requires the need for alternative methods of antimicrobial activity.  One spontaneous, 
naturally occurring bacterial disease model is pneumonia caused by Rhodococcus equi 
which is common in foals less than six months of age and immunocompromised humans.  
R. equi is a common and devastating pathogen frequently causing high morbidity and 
mortality from severe bronchopneumonia in young foals; however, immunocompetent 
adult horses are not susceptible to this intracellular pathogen.  Given the age-related 
susceptibility to disease in neonates, the need for alternative antimicrobial therapy is 
imperative.  Evidence demonstrates that plasma products reduce the incidence and 
severity of pneumonia in foals but the mechanism largely remains unknown.  We 
speculate that soluble immune complexes (sIC), present in plasma products, interact with 
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surface Fc-gamma receptors (FcɣR) on macrophages and may contribute to the success of 
equine plasma products in the prevention and decreased severity of clinical R. equi 
pneumonia.  Our study suggests that non-specific activation of macrophage FcɣR by sIC 
results in increased RONS.  Furthermore, the circulating sIC concentration within 
neonates is significantly lower than adults supporting speculation of the potential 
mechanism behind prophylactic treatment of hyperimmune plasma.  Importantly, a 
previous study demonstrated a reduction in the in vitro load of another macrophage-tropic 
intracellular pathogen, Leishmania amazonensis, through sIC stimulation of infected 
macrophages.  These results support our hypothesis that soluble immune complexes 
activate macrophages via the FcɣR resulting in intracellular killing of pathogens. It is 
plausible that these non-specific mechanisms apply to other macrophage-tropic 
intracellular pathogens. 
 
Introduction 
Rhodococcus equi  is a gram-positive coccobacillus bacterium that causes 
pneumonia in foals less than 6 months of age.  There are multiple mechanisms imparted 
by the virulence plasmid to enhance virulence including those that evade the 
phagolysosome. Neonatal pulmonary alveolar macrophages (PAM) have been identified 
as deficient in their production of superoxide and peroxynitrite contributing to fulminant 
early-onset pneumonia[1].  This indicates a defect in fundamental lung defense 
mechanisms during this developmental period. A potential mechanism that can be used to 
enhance the host immune response to intracellular bacterial infections involves 
modulating the interaction between Fc gamma receptors (FcɣR) on the surface of 
macrophages, including PAM, with naturally circulating soluble immune complexes 
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(sIC).  Expressed on the surface of macrophages, ligation of FcɣR aid in phagocytosis 
and superoxide production [2]; both of these macrophage functions are required for 
killing of intracellular pathogens like R. equi [3].  Previous studies have demonstrated 
that the interaction of immune complexes (IC) with FcɣR expressed on the surface of 
macrophages results in antibody-dependent cellular cytotoxicity (ADCC), phagocytosis 
and superoxide generation [2]. Furthermore, clinical research has demonstrated that 
plasma products, not only limited to R. equi specific hyperimmune plasma, reduce the 
incidence and severity of pneumonia caused by R. equi in foals [4-10] but the precise 
mechanism remains unknown.  We speculate that foals have less circulating sIC than 
adult horses and that sIC, present within plasma products, provide protection to foals by 
interacting with surface FcɣR and contribute to the protective effect of equine plasma 
products.   
In this study, sIC were isolated from the serum of neonatal and adult horses and 
their concentrations were compared using a commercial kit turbidometric assay.  The sIC 
were also measured for protein content and tested for specificity with an anti-equine IgG 
antibody through western blot analysis.  The in vitro biologic role of macrophage 
activation through stimulation with sIC was investigated through ROS fluorometric 
assays.  Building upon a previously identified mechanism using sIC to enhance 
intracellular killing of pathogens like R. equi through the upregulation of reactive 
intermediates, intracellular killing of R. equi was quantified.  Through the use of our 
well-established in vitro protocol utilizing PAM, we have demonstrated the ability to 
enhance superoxide production through the in vitro stimulation of macrophages with 
naturally occurring circulating soluble immune complexes.  We speculate that sIC, which 
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are comprised of circulating immunoglobulin, mainly IgG and antigen, interact with 
surface FcɣR on macrophages.  Ligation of and signal transduction by FcɣR expressed on 
the surface of macrophages initiate phagocytosis and superoxide production, a common 
mechanism for killing of intracellular pathogens [2].  Our preliminary data suggest that 
non-specific activation of macrophage FcɣR by sIC result in increased ROS production.  
Our goals are to characterize the concentration of circulating sIC within neonates 
compared to adults and to investigate sIC ability to upregulate ROS.  The results of this 
study are expected to provide insight into alternative methods of bacterial control for 
diseases affecting both animals and humans.   
 
Materials and Methods 
 
Sample Collection  
Serum samples were collected via venipuncture in red top tubes (RTT) from foals 
and adult horses upon admission to the Iowa State University Lloyd Veterinary Medical 
Center after receiving the Iowa State University Institutional Animal Care and Use 
Committee (IACUC) approval as well as the owner’s informed consent.  After proper clot 
formation, the sera samples were centrifuged for 10 minutes and the serum was aspirated 
and stored at -20° C for future analysis.  Bronchoalveolar lavages (BAL) were performed 
on adult horses as previously described [11].  Adult horses were sedated with intravenous 
detomidine (0.01 mg/kg) and butorphanol (0.01 mg/kg) prior to the procedure.  A 
sterilized Olympus VQ-8303A (9 mm OD) video-endoscope was used to identify the 
airway of interest.  Mepivicaine (2%) was instilled during advancement of the endoscope 
to limit coughing and discomfort. Lavages were performed using 480 mL of sterile saline 
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in 60 mL aliquots in the adult.  Similarly, a sterilized Olympus GIF-XP160 280 (5.9 mm 
OD) pediatric videoendoscope was used with 280 mL of sterile saline in 35 mL aliquots 
for obtaining bronchoalveolar lavages from heavily sedated foals (0.8 mg/kg xylazine IV; 
5.0 mg butorphanol IV).  After insertion of the endoscope into the elected site, cells were 
harvested in syringes by aspiration of the instilled saline.   
Remaining fluid was placed into 50 mL conical tubes and centrifuged at 500 x g 
for 10 minutes at 4° C.  Pellets were washed using PBS (Mediatech, CellGro, Inc., 
Manassas, VA) containing decreasing amounts of antibiotic/antimycotic (Lonza, 
Morristown, NJ) (wash 1: 2.5 µg amphotericin-b/mL; wash 2: 0.1 µg amphotericin-b/mL, 
2 U of penicillin/mL, and 2 U streptomycin/mL).  Cells were pelleted after wash 2 and 
resuspended in freezing medium containing 90% fetal bovine serum (FBS) (Atlanta 
Biologicals Inc., Flowery Branch, GA) and 10% DMSO (Sigma-Aldrich, St. Louis, MO). 
Cells were placed in an isopropanol Mr. Frosty® freezing container (Nalgene, Penfield, 
NY) at -80° C for 24-72 hours prior to transfer to liquid nitrogen. 
 
Soluble Immune Complex (sIC) Isolation via PEG6000 Precipitation 
Serum samples were thawed and immediately mixed with an equal volume of 5% 
PEG 6000 with 0.1 M HEPES (Hampton Research Corp., Aliso Viejo, CA) and left to 
stand at 4° C overnight before the precipitates were purified and washed using a modified 
protocol from a previously described method [12, 13].  Briefly, after overnight 
incubation, the sera:PEG sample was centrifuged at 2,100 x g at 4° C for 20 minutes to 
pellet the sIC and the remaining serum was either discarded or saved for further analysis.  
The pelleted precipitates were reconstituted with ice-cold sterile PBS (Mediatech 
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CellGro, Inc., Manassas, VA) to the original volume of serum. The PEG precipitates 
were stored at 4° C until used in cell culture experiments. 
 
Immunoglobulin, sIC and Protein Concentration Analysis 
The protein concentrations from the sIC sample and the sera that it was derived 
from were analyzed using the BCA assay (Pierce Technologies, Waltham, MA) as well 
as the Nanodrop1000 (Thermo Scientific, Waltham, MA).  The immunoglobulin 
concentration of the serum and respective sIC were tested using a turbidimetric 
immunoassay read at 530 nm (DVM Rapid Test II®, Value Diagnostics, Sarasota, FL).  
The test result is reported as mg/dL. 
 
Western Blot Analysis 
Samples containing sIC isolated from serum were quantified using a NanoDrop, 
and 10 ng of total protein from each sample were added to appropriate wells of a NuPage 
4-12% Bis-Tris Gel (ThermoScientific, Waltham, MA).  The gel was run according to 
standard denaturing western blot procedures [14].  Briefly, the gel was run using a Bis-
Tris buffer with an SDS denaturing incubation step prior to loading the samples onto the 
gel.  The resulting gel was then transferred to a nitrocellulose membrane, blocked, and 
incubated with a goat-anti-horse IgG antibody conjugated with an HRP tag (KPL, 
SeraCare, Milford, MA) used for visualization. 
 
Bacterial Growth and Concentration Determination  
Rhodococcus equi  (ATCC 33701) was streaked from glycerol stocks onto a TSA-
II plate (BD, Franklin Lakes, NJ) and incubated at 37° C, 5% CO2 for 48 hours.  A single 
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colony was then streaked for isolation and incubated at 37° C, 5% CO2 for 36 hours on 
TSAII plate (BD, Franklin Lakes, NJ).  All growth was removed from the 36-hour 
growth plate using a sterile loop and the colonies were placed into 10 mL of sterile BHI 
broth (BD, Franklin Lakes, NJ) and shaken at 37° C, 5% CO2 for 15 minutes in order to 
homogenize the broth.  A dilution yielding an OD600 = 0.300 was recovered, which 
corresponded to a bacterial concentration of approximately 5.5 x 108 CFU/mL, for 
infection of macrophages.   
 
R. equi Macrophage Infection and Lyse and Plate Protocol 
Murine macrophages (RAW264.7) were plated at a density of 100,000/well in a 
96 well plate and incubated at 37° C, 5% CO2 overnight and subsequently infected with 
R. equi (ATCC 33701; and Strain T194, ISU Clinical Isolate) with an MOI of 200:1 for 3 
hours at 37° C, 5% CO2.  The cells were then washed with 100 µL of warm PBS and 
media with 50 µg/mL of geneticin (CalBioChem, San Diego, CA) was applied to the 
cells in order to kill extracellular bacteria. The cells were then incubated for 24 hours at 
37° C, 5% CO2.  The next day, the supernatant was removed and a 0.05% Triton X-100 
(ThermoScientific, Waltham, MA) solution was applied to the cells for 5 minutes. Ten-
fold serial dilutions were performed and plated for visual quantification following a 24-
72-hour incubation at 37° C, 5% CO2.  
 
Statistical Analysis 
Sample means were found for the sIC, IgG, protein and ROS values using the 
statistical software package, GraphPad Prism 5 (La Jolla, CA).  For respective 
populations, a T test or paired T test, where appropriate, was conducted and graphs were 
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generated using GraphPadPrism 5 software (La Jolla, CA). Statistical significance was 
accepted at a p-value < 0.05.   
 
Results  
 
Foals Have Significantly Less Circulating sIC than Adult Horses 
Soluble immune complexes were isolated from the blood of neonatal and adult 
horses using a PEG precipitation method as described above.  The immunoglobulin and 
sIC concentrations were measured using a turbidometric method according the 
manufacturer’s instructions (DVM Rapid Test II®, Value Diagnostics, Sarasota, FL).  
Neonatal foals do not have any circulating sIC prior to colostrum ingestion (Figure 4-1).  
Following colostrum ingestion, neonatal horses have significantly less circulating sIC (p 
< 0.0001) when compared to adult horses (Figure 4-2).   
 
The Ratios of Immunoglobulin and Protein within sIC are Significantly Different 
Between the Foal and Adult 
Soluble immune complexes are composed of immunoglobulin and their cognate 
antigen or protein.  Concerning the composition of the sIC from foals, foals have both 
less protein content and immunoglobulin content within their sIC concentrations.  When 
comparing IgG content within serum to IgG content within the sIC that was isolated from 
the serum, the foals have higher ratios because their IgG and protein concentrations are 
significantly lower within their sIC than in their sera (Figure 4-3A; 4-3B).  Given that 
following colostrum intake, the serum concentration of IgG does not significantly differ 
between foals and adults (data not shown, p > 0.1), the difference is in the number of sIC 
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within their circulation as well as the protein, likely antigen, content within those sIC  
(Figure 4-3, p < 0.01).  However, foals have a lower range of normal serum protein 
concentrations when compared to adult horses so their higher protein ratio is not 
unexpected [15, 16].  
 
Soluble Immune Complexes are Specific for Equine Immunoglobulin 
Immunoglobulin molecules are approximately 150 kDa in size while sIC are 
larger and measure approximately >150 kDa[17] .  Preliminary western blot analysis 
demonstrates the presence of equine IgG within the isolated sIC (Figure 4-4).  
Furthermore, the western blot image shows the IgG heavy chain and light chain at 75 kDa 
and 28 kDa, respectively (Figure 4-4).  The precipitation of sIC via the PEG precipitation 
method is based on aggregation of sIC on a charge and size basis and is relatively 
selective for immune complexes; however, this method may also precipitate other high 
molecular weight proteins as previously mentioned [18, 19].  In order to confirm 
specificity of the anti-equine IgG antibody, ovalbumin and murine IgG were loaded as a 
negative control and did not display any banding pattern (data not shown).  
 
 
Macrophage Stimulation with sIC Results in an Increase in ROS Production 
The biological activity of the isolated equine sIC was investigated through in vitro 
ROS studies.  Two macrophage sources were used to investigate production of ROS as a 
result of sIC macrophage stimulation.  RAW264.7 were plated at a density of 100,000 
cells/well in a 96-well black plate.  They were rested overnight, stimulated with 50-100 
µg/mL of equine sIC, isolated from three different adult horses, and simultaneously 
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stimulated with 10 ng/mL of recombinant IFN-γ (R&D Systems, Minneapolis, MN) for 
72 hours.  Following 72 hours of stimulation, DHE (25 µM) (Life Technologies, CA) was 
incubated and a fluorimetry reading at 544/620 nm excitation/emission spectrum, 
respectively, was obtained following removal of the supernatant.  Figure 4-5A 
demonstrates that following stimulation with IFN-γ and sIC, macrophages significantly 
increase their production of reactive oxygen species.  The sIC from these three adults 
were each tested in two separate experiments.  For the second macrophage source, equine 
PAM were isolated using culture adherence techniques following a BAL, from adult 
horses and were plated at a density of 50,000 cells/well and allowed to rest overnight at 
37° C, 5% CO2.  The following day, the PAM were stimulated with 10 ng/mL of equine 
IFN-γ and 50-100 µg/mL of equine sIC isolated from donor horse serum (DHS) 
(Mediatech, CellGro, Manassas, VA).  Following 72 hours of stimulation, DHE (25 µM) 
was incubated and a fluorimetry reading at 544/620 nm excitation/emission spectrum, 
respectively, was obtained following removal of the supernatant.  Compared to the 
unstimulated PAM, the PAM that were stimulated with the DHS sIC showed 
approximately 2.5 times more ROS production (Figure 4-5B).  A positive control of 
synthetically made sIC (equine IgG and ovalbumin) resulted in a two-fold increase in 
ROS production compared to the unstimulated cells (Figure 4-5B).  Although these 
results were not significant, a trend consistent with the previous data can be observed.  
Due to limited quantities of primary equine pulmonary alveolar macrophages, this 
experiment was not repeated.  
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Discussion  
Soluble immune complexes and their function within the body have previously 
been studied in the context of autoimmune diseases such as in patients with rheumatoid 
arthritis and systemic lupus.  In these diseases, the mechanism of action of both soluble 
and insoluble immune complexes exacerbates inflammation due to production of reactive 
oxygen species and/or release of peroxidase enzymes making these immune complexes 
undesirable in these patients.  Conversely, though undesirable in autoimmune disease, 
their presence may play a role providing protection against infections; however, this has 
been largely overlooked during physiologic states of health and the literature exploring 
this concept is lacking.  In this study, a potential mechanism of action regarding the 
prophylactic effect of hyperimmune serum has been proposed.  A decrease in the 
incidence and severity of pneumonia in foals has been clinically demonstrated through 
the prophylactic use of plasma products [4-10] but results are controversial and the 
mechanism largely remains unknown other than success has been observed independent 
of the source of plasma, i.e., Clostridial spp. Streptococcus spp. vs. Rhodococcus equi  
specific hyperimmune plasma. We speculate that sIC present within hyperimmune 
plasma products  interact with surface Fc gamma receptors (FcɣR) on macrophages and 
may contribute to the success of these equine plasma products by aiding in ADCC, 
phagocytosis and superoxide production [2].  In the context of intracellular killing of 
pathogens, these mechanisms are not only favored but required for killing of intracellular 
pathogens like R. equi [3].   
For this study, soluble immune complexes were isolated from foals and adults 
using a previously published method [13].  Circulating soluble immune complexes were 
found at significantly lower concentrations than sIC within the adult circulation.  Foals 
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rely mainly on maternal antibody acquired by passive transfer through ingestion of 
colostrum.  Although limited in isotypes, an array of endogenous antibody production 
including IgG1, IgG3, IgG5 and IgA within the foal matures by three months of age but it 
is not until one year of age that all immunoglobulin-G antibody isotypes including IgG4, 
IgG7 as well as IgE can be isolated [20].  Thus, the lack of environmental exposure of 
antigen coupled with a limited quantity of circulating antibody would be predicted to 
result in lower systemic concentrations of sIC (Figure 4-1, p < 0.05).  Furthermore, due to 
a lack of environmental exposure, it is possible that the circulating immunoglobulins 
received from passive immunity remain uncomplexed.  In other words, the 
immunoglobulins present in neonates are free antibodies and are not complexed with 
their cognate antigen rendering them unable to cross-link FcγR on the surface of 
macrophages and signal through the immunoreceptor tyrosine-based activation motif 
(ITAM).  It is also plausible that what sIC are present post-ingestion of colostrum 
originate from the dam.  
Here we investigated the concentration of sIC within neonates and adults as well 
as their ability to activate macrophages through ROS quantification.  It should be stated 
that great variability was observed when testing sIC from various adults specifically in 
the in vitro macrophage stimulation ROS assays.  A potential reason for this variability 
may include the various immunoglobulin isotypes present within the sIC and their varied 
interactions with FcγR, as not all isotypes signal through ITAM activation, as well as the 
amount and type of antigen or protein present.  For future directions, complete 
characterization of the sIC is needed in order to determine the isotype of immunoglobulin 
present within those isolated sIC, as well as the amount of antigen or protein present and 
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if there are other serum proteins that aggregated during the PEG incubation as well as the 
associated variation between individuals.  Concerning the formation and composition of 
IC in vivo, individual variation is vast making repeated isolations from different equine 
patients and subsequent use during in vitro assays challenging.  For instance, Fossati et 
al. states that when making synthetic soluble immune complexes in the laboratory,  120 
µg/ml of antigen in concert with 80 µg of antibody is needed; if not enough antigen is 
present then insoluble complexes are formed when antigen concentrations reach only 20 
µg/ml [21].  The variability due to the antibody isotype and zone of equivalence (ratio of 
antigen to antibody) can greatly impact the functionality of the IC stimulation [21].  For 
this reason, a comprehensive characterization is needed following isolation of sIC from 
subjects.  Subsequent to a thorough and repeatable sIC characterization, sIC can be used 
in order to study their intracellular killing abilities after incubation with macrophages 
infected with R. equi.  This observed variability could also be the reason behind the 
controversial results observed with equine hyperimmune plasma [22].  Concerning VapA 
specific IgG isotypes, Sanz et al. observed coefficients of variance between 17 and 123 
per cent between various lots and manufacturers of hyperimmune plasma product [22].   
In order to better assess sIC as an alternative antimicrobial therapy, the 
macrophage (RAW264.7) infection and stimulation with IFN-γ and sIC protocol needs to 
be optimized as these experiments were repeated several times and yielded equivocal 
results.  Prior to forming firm conclusions regarding sIC upregulation of intracellular 
bacterial killing, the bacterial infection protocol needs optimization as well as the lyse 
and plate method for growth of R. equi and subsequent macrophage infection protocols.  
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Collectively, these results support the notion that soluble immune complexes 
activate macrophages via FcɣR resulting in an increase in ROS and presumably antibody 
dependent killing of intracellular bacteria as previously demonstrated using Leishmania 
amazonensis [23].  The central hypothesis of the proposed experiments is that neonates 
have lower concentrations of sIC than adults and that these sIC upregulate bactericidal 
activity of pulmonary alveolar macrophages.  The implications of these non-specific 
alternative antimicrobial therapies are broad and are expected to apply to other pathogens 
such as Salmonella spp., Mycobacterium spp., and Leishmania spp. etc.  The results of 
this study are anticipated to provide insight into innovative strategies for novel 
mechanisms of bacterial control of intracellular pathogens that threaten horses or other 
mammalian species. Ultimately, the outcomes of future studies are expected to enable the 
development of alternative antimicrobial therapies, decreasing the dependency on 
antibiotics. 
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Figures  
 
 
 
Figure 4-1. Soluble immune complex concentrations in foals before and after 
ingestion of colostrum.  sIC were isolated using a PEG protocol and were measured 
using a turbidimetric immunoassay which was read at 530nm (DVM Rapid Test II, Value 
Diagnostics).  These results demonstrate the proof of concept that sIC are not present 
prior to external provision of colostrum or intravenous plasma and provide an assay 
control for the PEG isolation of soluble immune complexes.  Prior to colostrum 
ingestion, foals do not have any circulating immunoglobulin and therefore, no soluble 
immune complexes are present. Graphs and statistics were generated using GraphPad 
Prism 5 (GraphPad software, La Jolla, CA) using a paired T test analysis. n=12 neonatal 
horses. **p < 0.001 
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Figure 4-2. Age-related differences in soluble immune complex concentration of 
equine sera. sIC were isolated as described above. Results demonstrate the significantly 
lower concentration of sIC within neonatal sera compared to adult. n=39 horses (12 
neonates, 28 adults). Data is displayed as a box and whisker plot and statistics were 
generated using GraphPad Prism 5 (La Jolla, CA) through a Student’s T-test analysis.  
***p < 0.0001 
 
88 
 
 
 
Figure 4-3.  Ratios of immunoglobulin/protein concentration in serum respective to 
sIC concentration. sIC were isolated as described above.  A ratio was made using serum 
IgG concentration to sIC IgG concentration. There is a higher IgG ratio in foals due to a 
lower sIC concentration of immunoglobulins when compared to adult ratios p < 
0.0001(A).  A similar pattern is present when comparing sera protein concentrations to 
protein concentrations within sIC , although given that healthy foals naturally have less 
serum protein than adults this is not unexpected p < 0.01 (B) as well as the remaining 
protein content within the supernatant from the PEG isolation p < 0.0001(C).  Adults also 
have significantly more protein within their sIC than foals p < 0.01(D).  
 
 
89 
 
 
 
 
Figure 4-4. Western blot analysis of equine sIC samples.  sIC were isolated from 
serum samples as described above.  The supernatant from one of the sIC samples was run 
for comparison of IgG content isolated in the sIC sample.  Murine sIC samples and 
ovalbumin were used as negative controls to confirm equine antibody specificity (data 
not shown).  Samples of equal protein (10 ng) content were loaded into each well of a 
NuPage 4-12% Bis-Tris Gel (ThermoScientific, Waltham, MA), following a denaturing 
SDS incubation step, ran and then transferred to a nitrocellulose membrane.  An equine 
anti-IgG-HRP antibody (KPL, SeraCare, Milford, MA) was then incubated and 
visualized. n= 2 adults. 
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Figure 4-5. Macrophage superoxide production following stimulation with sIC in 
two macrophage cell sources.  A) Superoxide production increases with prolonged in 
vitro stimulation of RAW264.7 with PEG precipitated soluble immune complexes (sIC).  
RAW264.7 were plated at a density of 100,000/well in a 96 well black plate and 
incubated at 37° C, 5% CO2 overnight.  Then, either 1X PBS (negative control) or sIC 
were applied and incubated for 72 hours at 37° C, 5% CO2. The media was then removed 
and fresh media containing 25 µM DHE was applied for a 30-minute 37° C, 5% CO2 
incubation.  The graph displays superoxide production from in vitro RAW264.7 
stimulation with sIC isolated by PEG precipitation from three different adult horses and 
is representative of two separate experiments. The error bars represent SEM and p < 
0.0001.  B) Equine primary PAM were harvested via BALF, washed and isolated. The 
primary equine PAM were stimulated for 72 hours with PEG-precipitated sIC from donor 
horse sera (Corning, Corning, NY).  Briefly, a 96-well plate was seeded with 
approximately 50,0000 PAM/well (mixed population) in duplicates.  Then, either 1X 
PBS (negative control) or sIC (from DHS or synthetic sIC made from eq. IgG + 
ovalbumin) were applied and incubated for 72 hours at 37° C, 5% CO2.  Synthetic sIC 
were created by incubating 1:1 of DHS with ovalbumin at 37° C, 5% CO2 for 12 hours. 
The media was then removed and fresh media containing 25 µM DHE was applied for a 
30 minutes 37° C, 5% CO2 incubation.  In both A and B, recombinant equine interferon 
gamma (10 ng/mL; R&D Systems) was applied simultaneously as the sIC stimulation to 
upregulate the FcγR. ROS were measured via RFU using an OMEGA plate reader at 
544/620nm excitation/emission, respectively.  Trends were similar although there was no 
statistical significance.  
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CHAPTER 5.    GENERAL CONCLUSIONS 
The development of the immune system is a complex, dynamic, and ever-
adapting network of cellular communication that changes throughout the life of an 
organism.  Orchestration between genetic programming, nutrition and a plastic response 
to ever-changing environmental antigens all influence neonatal immune development.  
Early neonatal development of the immune system is a multifaceted subject and varies 
not only according to age but species as well.  Largely, across all species, the neonatal 
immune system renders them more susceptible to disease, particularly pneumonia, when 
compared to the healthy adult [1].   
Specifically, within the adult horse, the immune system is able to mount an 
effective Th1- or pro-inflammatory immune response against a pathogen like R. equi 
effectively clearing the organism via a robust phagocytic respiratory burst before it ever 
causes an infection within the host.  Despite the fact that the field of equine neonatal 
immunology has made significant progress over recent years, gaps remain particularly 
with respect to site-specific immune responses to intracellular pathogens like R. equi.  
These gaps are most evident relating to site-specific pulmonary cytokine and cellular 
changes that occur within the first year of a foal’s life.  How these changes impact the 
principal cell that succumbs to infection with R. equi, the macrophage, remain yet to be 
determined. 
 Furthermore, controversy exists as to whether foals are Th2-, regulatory-, or anti-
inflammatory- biased rendering them more susceptible to pneumonia due to an inability 
to mount an appropriate Th1- or pro-inflammatory response.  Insofar as these neonatal 
regulatory or anti-inflammatory-biased responses do not result in classically activated 
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macrophages that possess the ability for increased intracellular killing of macrophage-
tropic organisms through effective production of reactive oxygen and nitrogen species.  
The problem remains that, to date, no studies have investigated the pulmonary, site-
specific innate immune environment signals that initially established this immune bias.  
Previous equine studies removed PBMC from young foals and stimulated them ex vivo 
which demonstrated that foals were a virtually in capable of producing IL-4 [2].  Our 
studies were performed using in vivo stimulation of heat-kill R. equi followed by analysis 
of the cytokine profile within the BALF. 
The first two investigations contained in this dissertation sought to uncover the 
implicit bias of neonatal foal pulmonary alveolar macrophages by investigating their 
surrounding pulmonary cytokine milieu as well as how a pulmonary alveolar macrophage 
removed from that environment functioned through ex vivo bacterial infection assays.  
Furthermore, how the cytokine milieu as well as how macrophage phenotype and 
function changed over the first year of life were investigated.   
In the last investigation of this dissertation, age-related changes regarding 
circulating soluble immune complex concentration were investigated as an additional 
immune differential affecting macrophage phenotype within the neonatal foal.  Moreover, 
a potential mechanism of action behind the observed success, exemplified by a decrease 
in the incidence and severity of rhodococcal pneumonia in foals through prophylactic 
treatment with hyperimmune plasma, was offered. 
 
PAM from Foals are Biased Toward a Regulatory/Tissue Repair Phenotype 
The BALF from a cohort of foals was measured via ELISA for IL-4 and TNF-α 
concentrations at the following weeks of life: 1, 4, 8, 26, and 52.  In foals less than six 
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months of age, IL-4 concentrations were observed to be increased compared to later in 
life while TNF-α concentrations remained consistent over the first year of life in the foal.  
IL-4 is the chief cytokine that induces a regulatory or tissue repair phenotype of the 
macrophage and these data provide evidence contributing to the understanding of why 
foal PAM are less efficient killers of intracellular pathogens.  These data also reveal a 
potential reason explaining why foals are more susceptible to pneumonia caused by R. 
equi when compared to adults.  
 
Decreased Capacity for Foal Macrophages to Produce Reactive Intermediates  
The PAM and PBMC from the same cohort of foals were isolated from the BALF 
and blood, respectively, and were analyzed, ex vivo, for production of reactive 
intermediates and cytokine expression and then compared to the cells similarly derived 
and tested from adult horses.  Fluorimetry was used in order to measure the production of 
superoxide, via DHE, and peroxynitrite, via DHR, in foal and adult macrophages 
following in vitro infection with R. equi, strain T194 transformed with either dsRed or 
GFP.  Bacterial load was measured using fluorimetry.  The results demonstrated that foal 
PAM and MDM contained significantly higher intracellular loads of R. equi while 
simultaneously producing less reactive intermediates when compared to the adult PAM 
and MDM.  These results indicate that foal PAM and MDM removed from their 
immediate environment have a dampened microbicidal function compared to the adult.   
To investigate an extrinsic mechanism behind macrophage activation, foal and 
adult pulmonary alveolar macrophages and monocyte derived macrophages were 
stimulated with CHO cells expressing ectopic equine CD154 [3], a receptor present on 
lymphocytes that functions to activate antigen-presenting cells following its binding to 
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CD40.  Following stimulation, reactive intermediate production in foal macrophages was 
of significantly less magnitude than reactive intermediate production from adult 
macrophages exogenously stimulated in the same manner.  Ultimately, these data support 
the hypothesis that PAM from foals are biased toward a regulatory- or tissue repair- 
phenotype.  
 
Decreased Circulating sIC in Foals Compared to Adults 
To investigate another potential inciting cause behind the inherent bias of the 
regulatory and tissue repair macrophage phenotype observed in foals, concentrations of 
soluble immune complexes were measured in neonatal foals and compared to 
corresponding concentrations in adults.  Soluble immune complexes activate 
macrophages by binding to Fc gamma receptors  (FcγR) present on the surface of 
macrophages [4].  Previous work has demonstrated an alternative mechanism for 
intracellular killing of Leishmania amazonensis through macrophage activation via cross-
linking of immune complexes bound to FcγR [5].  Furthermore, given the reported 
success of the prophylactic use of equine hyperimmune plasma in reducing the severity 
and incidence of pneumonia caused by R. equi [6-10], a potential hypothesis was offered 
regarding soluble immune complex activation as a prospective mechanism.   
Blood was drawn from neonatal foals and adults and sIC were isolated using a 
PEG6000 precipitation method previously published [11].  The sIC concentration of 
neonatal foals 12 hours following colostrum ingestion was significantly lower than when 
compared to the adult concentrations despite no significant difference between the 
immunoglobulin concentration.  Additionally, foals had significantly less protein content 
within their measured sIC than compared to the adult although this is less impactful given 
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the lower normal concentration range of sera protein from neonatal foals.  Collectively, 
these data support the hypothesis that foals have less circulating sIC than adult horses.   
 
Future Directions  
Several potential reasons why foals have an increased susceptibility to pneumonia 
caused by R. equi were uncovered within these investigations; however, the full picture 
remains elusive.  Site-specific baseline cytokine populations need to be characterized 
overtime to reveal other important changes.  Of note, IFN-γ, IL-10, IL-12, IL-13, IL-1β 
baseline changes within the BALF over the first year of life would be particularly 
interesting to characterize to uncover a greater picture of the true milieu.  In concert with 
the change in cellular population, chemokines specific to the changing cell population 
would increase understanding of the spatiotemporal control and aid in determining the 
phenotypic changes of all cellular populations, especially the lymphocytes, both within 
the BALF as well as the systemic circulation.  This information would aid in determining 
if BALF lymphocytes were also virtually incapable of Th2 responses or tissue repair- and 
anti-inflammatory responses similar to PBMC responses previously observed [2]. 
Aside from increasing the knowledge regarding a more complete cytokine milieu 
profile as well as a complete phenotypic cellular characterization across time, 
determining the source, particularly of IL-4, would increase knowledge of innate 
immunity uncovering potential new mechanisms behind neonatal immune responses to 
pathogens.  Determining the cellular source of the characterized cytokines may be 
investigated through mRNA expression or in situ hybridization of tissue collected from 
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aging foals.  This could potentially reveal immune functions of cells previously not 
regarded within innate immune realm.  
Regarding the macrophage function, despite the various stimulants and in vitro 
mechanisms employed, the functionality of the foal macrophage could not be overcome 
via exogenous activation (equine reIFN-γ, TLR activation (heat killed R. equi), CD154, 
and sIC).  This suggests that the external environment may not be all that is implicated 
regarding reduced functionality within foal macrophages.  Therefore, determining which 
extrinsic factors are needed for macrophage function as well as which inherent 
macrophage mechanisms, or lack thereof, are responsible for this reduced functionality is 
vital.   Investigating a potential combination of extrinsic factors working in concert with 
inherent macrophage mechanisms may reveal a reason for the observed decreased 
capacity for reactive intermediate production.  Specifically, regarding external factors, 
recent attention has been given to IL-25, IL-33, and TSLP in priming type 2 immunity 
and activating innate lymphoid cell 2 (ILC2) [12, 18].   
Intrinsically related to the macrophage, studying metabolic shifts regarding 
macrophage activation could provide a potential new area to study regarding these age-
related changes as well as how these cells function on a physiologic basis [13].  
Additionally, characterization of the downstream signaling pathways juxtaposing adult 
from neonatal macrophages could uncover a novel avenue for alternative treatments to 
address epigenetic changes that alter immune function in neonates not only in 
macrophages but lymphocytes as well.   
Concerning lymphocytes, recent studies have demonstrated that T cell epigenetic 
changes such as differential methylation of the Th2 locus are different between neonates 
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and adults making neonatal immune responses primed toward Th2 cytokine production 
and subsequent development of Th2 effector cells  [14].  Interesting, Ribeiro‐do‐Couto et 
al.  reported that naïve Th cells recovered from the umbilical cord produced significant 
amounts of another Th2 cytokine, IL-13 [15].  Furthermore,  Webster et al. discovered a 
potential reason for this including epigenetic changes related to differences in chromatin 
structure causing hypersensitivity, hypomethylation, and permissive histone 
modifications present in Th2 cells [16].   
Furthermore, exploring the pulmonary milieu of receptor expression among 
immune cells is intriguing.  Two types of IL-4 receptors exist.  Type 1 exclusively binds 
IL-4 and is comprised of IL-4Rα and γc  and type II, which binds both IL-4 and IL-13 
and is comprised of IL-4Rα and IL-13α-1 subunits [17, 18].  Interestingly, non-
hematopoietic cells express type II receptors while B and T cells express type 1 and 
macrophages express both types[18].  Evidence exists that downstream signaling events 
following IL-4 binding to the surface of macrophages depends on the presence of 
receptor expression, IL-4Rγc vs. IL-4Rα, and of cytokine availability[19, 20].  
Determining a difference in receptor expression in foal antigen presenting cells vs. adult 
antigen presenting cells may provide additional reasons that explain the propensity of foal 
macrophages to adopt a regulatory or tissue repair phenotype.  
Finally, a greater characterization of the antibody isotypes as well as the antigens 
contained within the circulating sIC population both in vivo from aging foals compared to 
adults and within hyperimmune plasma products is paramount.  Although success has 
been observed, the use of HIP to prevent pneumonia in foals caused by R. equi remain 
controversial and the different proportions of the seven different isotypes present within 
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HIP vary greatly lot to lot and supplier to supplier [21].  This observed variation could be 
a reason explaining the variable success rates reported in Chapter 4.  Furthermore, 
following identification of a consistent isolation, concentration ratio, and composition 
and characterization of sIC isolated from adults, sIC could be used to investigate 
macrophage activation and killing assays in order to determine an alternative mechanism 
for treatment of microbial infections.   
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APPENDIX. AGE-RELATED VARIATION IN THE CELLULAR 
COMPOSITION OF EQUINE BRONCHOALVEOLAR LAVAGE FLUID 
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Iowa State University, Departments of 1Veterinary Pathology, 2Veterinary 
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Modified from a manuscript published in the Journal of Veterinary Clinical Pathology. 
 
Background: Previous reports reveal variation in the cellular composition of equine 
bronchoalveolar lavage fluid (BALF). 
Objectives: The purpose of this study was to compare the profiles of BALF from horses 
to assess age-related differences.  Serial BALF samples were collected from the same 
individuals over a one-year period to identify changes in individual animals as they aged. 
Methods: Collection of BALF was performed on horses aged one week and one, 2, 6, 
and 12 months.  Total nucleated cell count (TNCC), protein concentration, and cytology 
were assessed.   Longitudinal analysis was performed and compared to healthy adults. 
Results: Foals at one week and 6 months of age had significantly higher TNCC than 
adults (medians: 320/µL, 285/µL, and 90/µL, respectively); no differences in total protein 
were found.  Foals at one month had the highest proportion of macrophages (median: 
87.3%), differing significantly from both yearlings and adults (medians: 45.5% and 
48.7%, respectively).  Foals aged one week and one month had significantly lower 
proportions of lymphocytes than yearlings and adults (medians: 3.2% and 4.7% vs 43.2% 
and 45.8%, respectively).  Eosinophil percentage was lowest in foals aged one week, one 
month, and 2 months (median: 0.0%) and highest in foals aged 6 months (median: 2.2%).  
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Mast cell percentages were highest in yearlings and adults (medians: 2.2% and 3.3%, 
respectively) and neutrophil percentage was highest in foals aged one week (13.7%). 
Conclusions: Cytologic profiles of BALF from foals and adult horses differed 
considerably.  Significant changes in TNCC and percentages of lymphocytes, 
macrophages, and eosinophils occurred with age. 
 
Introduction 
Bronchoalveolar lavage (BAL) is frequently performed as part of a diagnostic 
workup for equine respiratory disease.  Certain conditions are associated with altered 
cellular composition of bronchoalveolar lavage fluid (BALF).  Diseases causing impaired 
lower airway function in which BALF analysis is helpful in achieving a diagnosis and/or 
monitoring a response to therapy include, but are not limited to, recurrent airway 
obstruction, silicosis, exercise-induced pulmonary hemorrhage (EIPH), and inflammatory 
airway disease (IAD) [1–3].  Bronchoalveolar lavage is most commonly performed in 
mature horses; however, it is occasionally performed in foals for both research and 
clinical intentions.  Respiratory disease is a major cause of morbidity and mortality in 
foals, and BAL may be utilized in foals with clinical pneumonia that is refractory to 
treatment [4–6].  The cellular composition of BALF collected from horses with altered 
lower airway function is often characteristic for each disease entity; however, age-related 
differences in BALF have not been well characterized in a cohort of healthy horses.   
Age-related changes in the cellular composition of BALF have been well 
documented in human beings.  For example, an increase in total lymphocytes occurs in 
adults with age, and younger children are reported to have higher percentages of 
granulocytes than older children [7, 8].  An age-associated increase in the percentage of 
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lymphocytes in BALF collected from healthy adult Beagles was recently reported [9].  In 
the horse, immunophenotypic analysis of cells recovered from BALF revealed a 
decreasing CD4-to-CD8 lymphocyte ratio with age, as well as a higher proportion of 
lymphocytes in BALF from adult horses, supporting the notion that there is an age-
related difference in the resident cell population of equine airways as well [10].  
Recently, it was reported that healthy geriatric horses had an increased percentage of 
lymphocytes and a decreased percentage of macrophages in BALF when compared with 
young, healthy, and adult horses; similar age-dependent changes in mononuclear cell 
populations were identified in young foals [11,12].  In contrast, another study comparing 
airway inflammation in young adult vs. older sport horses found higher lymphocyte 
numbers in BALF collected from the younger age group [13].  These studies exemplify 
the need for age-specific data for proper cytologic evaluation of equine BALF. 
 In this study, we compared BALF cytology from healthy foals and adults with 
particular attention given to how resident cell populations evolve with age.  To further 
characterize the effect of age on resident cell populations in the lung, BALF samples 
from the same cohort of foals were collected over a one-year period beginning at one 
week of age to identify changes in cell populations over time. 
 
Materials and Methods 
Animals 
Inclusion criteria, prior to admission into the study, included a physical 
examination and a CBC, including leukocyte differential count and fibrinogen 
concentration within the respective RI.  Subjects included 4 Quarter horse colts, one 
Quarter horse filly, 4 Thoroughbred colts, and one Thoroughbred filly.  All study subjects 
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were housed in the same premise under similar conditions throughout the study.  
However, housing requirements varied slightly for each individual depending on birth 
date and age.  In general, decisions regarding housing reflected the environmental 
conditions of the temperate climate.  The subjects were housed in outdoor settings with a 
shelter available.  These shelters were Iowa State University Institutional Animal Care 
and Use Committee (IACUC) approved and monitored with consideration to air quality.  
For this longitudinal study, samples were collected at defined time points according to 
age of the subject, beginning at approximately one week of age and extending to 
approximately one year of age.  Specifically, BAL was performed on foals at the 
following ages (1–3 days): one week, one month, 2 months, 6 months, and 12 months.  
Adult samples were obtained from 4 healthy, adult geldings with no evidence of 
respiratory disease during exercise or at rest.  The geldings were routinely exercised 
under saddle and on the lunge line and no exercise intolerance or evidence of respiratory 
disease (cough, nasal discharge, etc.) were noted.  The geldings were 11, 13, 14, and 17 
years of age and of the following breeds: Appendix Quarter horse, 
Warmblood/Thoroughbred cross, and 2 Thoroughbreds, respectively.  The study was 
approved by the Iowa State University IACUC. 
 
Bronchoalveolar Lavage Technique 
Adult horses were sedated with intravenous detomidine (0.01 mg/kg) and 
butorphanol (0.01 mg/kg) prior to the procedure.  A sterilized Olympus VQ-8303A (9 
mm OD) videoendoscope was used to identify the airway of interest.  From the left main 
stem bronchus, the scope was advanced caudo-dorsally parallel to the median plane in the 
standing, sedated adult until the scope was gently wedged in the selected airway.  
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Mepivicaine (2% solution, not more than 20 mL) was instilled during advancement of the 
endoscope to limit coughing and discomfort.  Residual mepivicaine was immediately 
diluted with sterile saline used for the lavage.  Lavages were performed using 480 mL of 
0.9% sterile saline in 60 mL aliquots in the adult.  Similarly, a sterilized pediatric 
videoendoscope (GIF-XP160 280 [5.9 mm OD]; Olympus, Center Valley, PA, USA) was 
used with 280 mL of sterile saline in 35 mL aliquots for obtaining BALs from heavily 
sedated foals (0.8 mg/kg xylazine IV; 5.0 mg butorphanol IV).  In both foals and adults, 
the total volume of saline was utilized to perform the lavages.   Samples from individuals 
were pooled and 1 mL aliquots were submitted for analysis. 
 
BALF Analysis 
Total protein was determined on BALF using a refractometer (TS Meter; 
American Optical, Southbridge, MA, USA).  Total nucleated cell count (TNCC) was 
measured via laser flow cytometry using the ADVIA 120 hematology analyzer (Siemens 
Corporation, Washington, DC, USA).  Cytocentrifugation of BALF was performed using 
a Shandon Cytospin3 (ThermoScientific, Waltham, MA, USA) 72g for 10 min (low 
acceleration).  Air-dried slides were then stained with modified Wright’s on an automated 
stainer (Siemens Hematek; Siemens Corporation).  Determination of differential cell 
counts was done under 1000x magnification with oil immersion by counting 300 
nucleated cells (epithelial cells excluded) by a board-certified clinical pathologist (SJH) 
without knowledge of animal age and time point of collection. 
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Datasets and Statistical Analysis 
For analytic purpose, the samples were divided into 2 categories: a pooled dataset 
representing all samples collected and a second dataset representing BALF from foals for 
which samples were available at all time points throughout the study.  The adult group (n 
= 4) represented a third group that was not part of the longitudinal study but was included 
to better characterize potential age-related differences.  Normality tests (D’Agostino and 
Pearson tests) were performed on the datasets, and in some instances, the data were 
nonnormal; therefore, nonparametric tests were employed for all analyses.  Differences 
between age groups (pooled samples) for TNCC and cell differential counts were 
assessed using Kruskal–Wallis one-way ANOVA on ranks and Dunn’s test for multiple 
comparisons.  Friedman test for repeated measurements followed by Dunn’s multiple 
comparisons test were employed for the cohort group.  Results were considered 
significant at P < .05.  Statistical analysis was performed using NCSS10 Data Analysis 
(NCSS, LLC, Kaysville, Utah, USA) and GraphPad Prism (GraphPad Soft-ware, Inc., La 
Jolla, CA, USA) software. 
 
Results 
Study Population and BALF collection  
Although 10 foals were included in the study, BALF samples were available at 
every time point from only 4 foals (cohort group, n = 4).  Attrition of subjects occurred 
during the study at various time points due to a variety of reasons, including paddock 
accidents leading to euthanasia, illness unrelated to the study, and sale of yearlings.  As a 
result of this attrition, the number of BALF samples analyzed in each pooled age group is 
as follows: n = 10 (one week), n = 9 (one month), n = 9 (2 months), n = 8 (6 months), and 
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n = 6 (12 months).  Approximate retrieval volume of BALF volume was 90%.  No 
health-related difficulties encountered during the study were attributable to BALF 
collection.  BALF total protein and nucleated cell counts.  Total protein concentrations 
were negligible in BALF samples, and no significant differences were detected in total 
protein content between age groups (data not shown).  In contrast, TNCC differed 
significantly over time (P = .01, Kruskal–Wallis one-way ANOVA on ranks).  Adult 
horses had the lowest TNCC (median: 90 cells/µL) compared with higher counts for foals 
at one week (median: 320/µL), one month (median: 230/µL), 2 months (median: 
340/µL), 6 months (median: 285/µL), and one year (median: 205/µL).  Pairwise 
comparisons between age groups revealed that the BALF collected from foals aged one 
week and 6 months had significantly higher TNCCs than BALF collected from adult 
horses (P < .05, Figure A-1). 
 
BALF cytology 
The most profound changes in inflammatory cell percentages between age groups 
were found in mononuclear cells.  There was a significant difference in the proportion of 
macrophages within BALF between age groups (pooled data, P < .005, Kruskal–Wallis 
one-way ANOVA on ranks, Figure A-2A).  Foals at one month of age had the highest 
proportion of macrophages (median: 87.3%), followed by foals at one week of age 
(median: 81.6%), foals at 2 months of age (median: 66.0%), and foals at 6 months of age 
(median: 60.5%).  In contrast, BALF collected from yearlings and adult horses had lower 
proportions of macrophages (medians: 45.5%, and 48.7%, respectively).  Pairwise 
comparisons between age groups showed significant differences in macrophage 
percentages between one- month-old foals compared with both yearlings and adults (P < 
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.01 and P < .05, respectively).  Lymphocyte percentages within BALF also differed 
significantly between age groups (pooled data, P < .0001, Kruskal–Wallis one-way 
ANOVA on ranks, Figure A-2B).  Foals had a lower proportion of lymphocytes at age 
one week (median: 3.2%), one month (median: 4.7%), 2 months (median: 10.7%), and 6 
months (median: 28.0%) of age compared to adults (median: 45.8%).  The proportion of 
lymphocytes in yearlings was similar to adults (median: 43.2%).  Pairwise comparisons 
between age groups detected significant variation between the following age groups: one-
week-old foals vs 6-month-old foals, yearlings, and adult horses (P < .01, P < .0005, and 
P < .001, respectively, Figure A-2B), one-month-old foals vs yearlings and adult horses 
(P < .01, Figure A-2B).   
Neutrophil percentages were highest in foals aged one week (median: 13.7%) and 
lowest in adults (median: 2.7%; Figure A-2C); however, this difference was not 
statistically significant (P = .158).  The proportion of neutrophils at the other time points 
sampled was as follows: one-month median: 5.0%, 2-month median: 4.7%, 6-month 
median: 5.2%, and 12-month median: 4.0%, Figure A-3C.  There was a significant 
difference in eosinophil proportions between age groups overall (P < .005, Kruskal–
Wallis one-way ANOVA on ranks, Figure A-2D).  The percentage of eosinophils in 
BALF samples was lowest in foals at the first 3 time points sampled (median: 0.0% at 1 
week, 1 month, and 2 months) and highest in 6-month-old foals (median: 2.2%, Figure A-
3D).  Yearlings had a higher proportion of eosinophils than adults (medians 1.5% and 
0.3%, respectively).  Significant differences in eosinophil percentages between specific 
groups were found between 6-month-old foals and foals aged one week and one month 
(pairwise comparison, P < .01 and P < .05, respectively).  Lastly, the percentage of mast 
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cells in BALF tended to increase with age (Figure A-3E).  Foals aged one month and 2 
months had the lowest percentage of mast cells (median: 0.0%), followed by foals aged 
one week and 6 months (median: 0.3%).  A higher proportion of mast cells were found in 
yearlings (median: 2.2%) and adult horses (median: 3.3%).  Although the overall 
Kruskal–Wallis test for mast cell percentages had a P < .05, pairwise comparisons 
between groups failed to identify significant differences.  BALF cytology within the same 
cohort of foals over time.  Bronchoalveolar lavage fluid samples collected from the same 
4 horses over a one-year period exhibited similar temporal changes in the cell proportions 
(Figure A-3).  The proportion of lymphocytes in BALF significantly increased with age 
within the same cohort of individuals (P = .0005, Friedman test).  Pair-wise comparison 
between groups showed a significant difference in lymphocyte percentage in these 
animals at age one week and 12 months (median: 2.5% vs 37.7%, respectively, P < .05, 
Figure A-3A).  Similarly, the percentage of macrophages significantly decreased in 
BALF with age within the same cohort of foals (P < .005).  Significant differences 
between the foals at age one month and 12 months were identified via pairwise 
comparison (median: 90.0% vs 53.7%, respectively, Figure A-3A).  The tendency for 
decreasing neutrophil percentage, as well as increasing eosinophil and mast cell 
percentage with age was likewise noted within the cohort group (Figure A-3B).  The 
increase in eosinophil percentage over time within the cohort group was significant (P < 
.05); however, pairwise comparisons failed to identify significant differences at specific 
ages.   
Representative images of BALF from the same horse at various ages are provided 
for comparison (Figure A-4).   
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Discussion 
This study compared the cellular composition, protein content, and TNCC for 
BALF collected from healthy foals of various ages and adult horses.  Additionally, this is 
the first study to assess age-related changes within the same cohort of foals over a one-
year period.  Our results indicate significant differences in the proportion of both 
lymphocytes and macrophages present in BALF between foals and adult horses.  The 
percentages of both eosinophils and mast cells also varied between age groups: 
eosinophil percentage was highest in the 6-month-old group, while mast cell percentages 
tended to increase with age.  These differences emphasize the importance of considering 
age in the interpretation of BALF in the horse.   
In healthy adult horses, macrophages are typically the most common cell type 
recovered in BALF [14,15].  Macrophages are present at all levels of the respiratory tract 
but are particularly numerous in the terminal bronchioles and alveoli [16].  Macrophages 
are a major component of innate immunity, serving a multitude of functions including 
phagocytosis and killing of microbial pathogens, production of cytokines, and antigen 
presentation to lymphocytes [17].  Pulmonary alveolar macrophages (PAM) are the 
principal or only phagocyte tasked with clearance of foreign particles and microbial 
pathogens from the terminal airways and alveoli, particularly as the mucociliary 
apparatus serves the more proximal airways.  Within the distal airways and alveoli, 
macrophages can migrate away to become entrapped in the mucociliary apparatus, 
effectively acting as a shuttle mechanism, or can migrate to lymphatic or blood vessels 
for removal from the terminal airways [18].  Pulmonary alveolar macrophages also serve 
as antigen-presenting cells to initiate cell-mediated and humoral defenses; however, they 
are less effective at direct stimulation of T cells than resident macrophages in other 
114 
 
organs [19] The BALF cellular profiles from young foals in our study had a substantially 
higher percentage of macrophages (up to 1.89 higher) than adult horses, and the 
percentage of macrophages decreased with age.  In young animals, innate immunity may 
represent a more significant component of their pulmonary immune defense [20, 21].  To 
our knowledge, there are few studies describing an increased proportion of macrophages 
in BALF in the young of other species; however, this finding has been described 
previously in very young children.  Children in the youngest age group sampled (< 2 
years) had a significantly increased proportion of macrophages compared to children in 
the older age groups (2–5 years and 6–17 years).  In addition, the PAM collected from 
children within the youngest age group had decreased function  [22] The trend for a 
decreasing proportion of macrophages in BALF continues as people age, as elderly 
people are reported to have a lower percentage of macrophages than younger adults [21] 
Macrophages isolated from BALF of older adults released more superoxide in response 
to stimulation than macrophages from younger adults [23].  In swine, PAM isolated from 
younger pigs likewise showed decreased oxidative burst in response to stimuli than PAM 
from older pigs [24].  Additional studies are needed to determine if PAM function 
changes with age in the horse.   
Our data support the findings of previous studies suggesting that lymphocyte 
percentages in BALF increase with age in the horse [10–12, 25].  The relative increase in 
lymphocytes in BALF seen in adult horses compared with foals could reflect an increase 
in memory cells associated with increased antigen exposure.  To our knowledge, 
increased lymphocyte percentages in BALF are not currently associated with any specific 
equine respiratory diseases.  In human medicine, an increased percentage of lymphocytes 
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is considered evidence of inflammation in BALF, and has been associated with certain 
pathologic conditions such as bronchiolitis obliterans, Mycobacterium abscessus 
infection, and asbestos exposure [26–29].  It is therefore conceivable that as the use of 
BAL as a diagnostic tool in veterinary medicine evolves, an association between 
alterations in BALF lymphocyte proportions and specific respiratory conditions may be 
identified.   
Tendencies for a decreasing percentage of neutrophils in BALF concurrent with 
increasing percentages of mast cells and eosinophils were identified in the cohort 
population that was studied over one year, as well as in the pooled samples at those time 
points.  It may be worthwhile to consider the potential for age-related changes when 
interpreting BALF cytology, as most inflammatory conditions of young adult and aged 
horses are characterized, at least in part, by an increase in neutrophils, mast cells, and/or 
eosinophils.  For example, an increase in the percentage of one or more of these cell types 
is used to help define horses suffering from IAD (> 10% neutrophils, > 5% mast cells, > 
5% eosinophils—or any combination) [1, 30–33].  The youngest age group of foals 
sampled in this study (one week of age) had, on average, a higher proportion of 
neutrophils than the other age groups; however, this finding was not statistically 
significant.  Previous studies comparing BALF cytology between mature and immature 
subjects have likewise identified differences in neutrophil counts.  For example, studies in 
both human beings and dogs have identified an increased percentage of neutrophils in 
young animals compared with adults in health [7,9].  In an experimental mouse model, 
younger animals had a more pronounced inflammatory airway response to antigen than 
adult animals [34].  As neutrophils represent the first line of defense against pathogens 
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and are a primary effector cell of innate immunity, this increase could represent a normal 
physiologic response to inhalation of particulate matter after birth.  Alternatively, some of 
the foals included within our study could have suffered from subclinical respiratory 
disease during the neonatal period.  The neutrophil percentage decreased by the next time 
point (one month of age) to levels comparable to the adults.  The clinically healthy foals 
in this study also exhibited an increase in both eosinophils and mast cells by 6 months of 
age.  This increase could be caused by a variety of factors, such as maturation of 
pulmonary innate defense mechanisms, a normal response to typical housing conditions, 
chronic exposure to respirable particles, or some other effect that has not been 
definitively established.  Recently, a potential link between inhalable particulates and 
eosinophilic inflammation in BALF in Thoroughbreds entering training was established 
[35]. 
Regardless of cause, our study indicates a proclivity of healthy weanlings and 
yearlings to have modest increases in percentages of mast cells and eosinophils in BALF, 
and emphasizes the importance of interpreting changes in BALF cytology in the context 
of existing clinical signs.  The difference in TNCC between immature horses and adults 
was somewhat unexpected.  Although the approach to collection technique was similar, 
the endoscope used for BALF collection differed between young foals and adults.  
Nonetheless, the finding of higher TNCC in immature animals was still observed in 6-
month-old horses and in yearlings, where the larger endoscope was utilized to perform 
the lavages.  In the horse, higher TNCC counts were identified in young adult horses 
compared to an older age group in a prior study [13].  Consideration of an age-dependent 
effect on TNCC could be clinically relevant, as an elevated TNCC in BALF can be seen 
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with some respiratory diseases.  Specific inflammatory conditions associated with an 
increased TNCC in equine BALF include IAD and EIPH [1, 2, 36, 37].  Our finding that 
age can be associated with significant differences in TNCC in BALF from healthy horses 
could be of particular significance in the context of diagnosing IAD, a disease affecting 
horses of all ages, particularly young horses.  The BALF cytologic profile in horses with 
IAD is characterized by an increased TNCC as well as increased neutrophils, eosinophils, 
and/or mast cells [1].  Elevations in TNCC, however, are not specific for inflammation 
within the lower airways.  For example, higher TNCCs have previously been reported in 
children compared with adults [7].  In the horse, higher TNCC counts were identified in 
young adult horses compared to an older age group in a prior study [13].  Additionally, 
Thoroughbred colts in training have been shown to have higher BALF TNCC counts, as 
well as an increased percentage of neutrophils and eosinophils, when compared with 
stabled colts of similar age [38,39].  In this context, it is important for clinicians and 
clinical pathologists to recognize that although an increase in TNCC can occur with 
airway inflammation in horses, it is not specific for inflammation and should be 
interpreted in conjunction with the signalment, history, and clinical signs.  In conclusion, 
this study identified a progressive increase in the proportion of lymphocytes and a 
corresponding decrease in macrophages in BALF in horses with age.  Additionally, 
immature horses had higher TNCC in BALF than the adults sampled.  The cause for this 
age-related difference is unknown, and warrants further investigation.  These findings 
exemplify the potential importance of age as a possible variable in the interpretation of 
equine BALF.  As the clinical utility of BALF evaluation becomes more widely explored 
in younger horses, a larger study to establish age-specific RIs may be useful. 
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Figure A-1.  Box plot of total nucleated cell counts (TNCC) per microliters in 
bronchoalveolar lavage fluid (BALF) from horses at various ages. Foals at one week 
and 6 months of age had significantly higher TNCC than adult horses.  Data are 
expressed as median (horizontal line), interquartile range (box), and minimum/maximum 
value (whiskers; Kruskal–Wallis one‐way ANOVA on ranks and Dunn's test for multiple 
comparisons; *P < .02; **P < .05).  
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Figure A-2.  Temporal changes in percentages of macrophages (A), lymphocytes (B), 
neutrophils (C), eosinophils (D), and mast cells (E) in bronchoalveolar lavage fluid 
(BALF) samples taken from horses at various ages.  Horses at one month of age had a 
significantly higher percentage of macrophages than 12‐month‐old horses and adults (A; 
*P < .05; **P < .01).  Lymphocyte percentage was lowest in horses aged one week, and 
differed significantly from adult horses as well as 12‐ and 6‐month‐old horses (B; solid 
line; *P < .001; **P < .0005; ***P < .01, respectively).  Horses aged one month also had 
a significantly lower percentage of lymphocytes than adults and horses aged 12 months 
(B; dashed line; *P < .01; **P < .01).  Foals at one week of age had a higher median 
percentage of neutrophils than other age groups; however, this finding was not 
statistically significant (C).  Horses at 6 months of age had a significantly higher 
percentage of eosinophils than horses aged one week and one month (D; solid line, P < 
.01; dashed line, P < .05, respectively).  Mast cell percentage tended to increase with age, 
with adult horses having the highest median percentage (E).  Data are expressed as 
median (horizontal line), interquartile range (box), and minimum/maximum value 
(whiskers; Kruskal–Wallis one‐way ANOVA on ranks and Dunn's test for multiple 
comparisons). 
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Figure A-3.  Comparison of resident cell populations in bronchoalveolar lavage fluid 
collected from the same cohort of foals over a one‐year period.  Temporal changes 
were most profound in mononuclear cell populations (A).  The foals had significantly 
higher percentages of macrophages at one month compared with 12 months of age (*P < 
.05); lymphocyte percentages increased significantly over time (one week vs 12 months, 
**P < .05).  Trends for decreasing neutrophils and increasing mast cells and eosinophils 
also were noted (B); however, these changes were not statistically significant within the 
cohort (n = 4, data expressed as median and interquartile range.  One‐way repeated 
measures ANOVA on ranks (Friedman Test) with Dunn's test for multiple comparisons).  
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Figure A-4.  Representative photomicrographs of cytocentrifuge preparations of 
bronchoalveolar lavage fluid (BALF) sampled from the same horse at various ages, 
modified Wright's, ×100 objective.  (A) one week, (B) one month, (C) 6 months, and 
(D) 12 months. Note the greater proportion of macrophages relative to lymphocytes in the 
BALF sampled at ages one week, one month, and 6 months (A, B, and C) when 
compared to age 12 months (D). 
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